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ABSTRACT
Campylobacter jejuni and Campylobacter coli are the most common bacteria isolated in 
animals and humans suffering from diarrhoea. These organisms can also be found in 
animals which are clinically healthy. The most common sources of Campylobacter 
infection include undercooked meat, especially chicken, contaminated water, 
unpasteurized milk and raw milk.
Initially, the effects of storage temperature on the survival of C. jejuni were examined in 
pasteurized and UHT skimmed milk. It was found that, C. jejuni NCTC 11168 survived for 
more than 5 days at 4°C in both UHT and pasteurized milk but that at 25°C it survived for 
3 days in UHT milk and was not detectable after 6 h in pasteurized milk suggesting the 
presence of an antimicrobial system in the latter milk. C. jejuni was found to die at the 
same rate in pasteurized milk that had been filter sterilized to remove the residual micro­
flora. This result indicates that the antimicrobial effect was not due to the natural flora but 
to a natural component in the milk.
The inhibitory action of pasteurized milk was prevented by boiling and by addition of 1 
mM of sodium meta-bisulphite (a specific inhibitor of lactoperoxidase) suggesting that 
lactoperoxidase in the pasteurized milk was responsible. This was confirmed by restoration 
of the inhibitory effect in UHT milk by addition of components of the lactoperoxidase 
system.
When tested in pasteurized milk, and with the lactoperoxidase system, other foodbome 
pathogens such as Salmonella, Listeria monocytogenes and E. coli 0157 survived without 
significant reductions in viability indicating the unique sensitivity of Campylobacter to the 
lactoperoxidase system. This finding was exploited and this system was found to be 
effective at eliminating Campylobacters from artificial surfaces but not from chicken meat 
surfaces.
A gene encoding the catalase from C. jejuni was cloned, an antibiotic marker inserted and 
allelic exchange used to generate a catalase-deficient mutant (katA). This was assessed for 
its sensitivity to the LPO system. The mutant C. jejuni was shown to be less sensitive to 
killing by LPO system compared to the parental strains. Other mutants deficient in Cgb 
(nitrosative stress resistance), and SodB (superoxide dismutase) were also compared to the
wild type strains and shown to be less sensitive to LPO system. This unexpected result is 
unexplained but could be investigated more in future work.
This study also addressed the effect of xanthine oxidase (XO) as this is another 
antimicrobial enzyme that exists in milk. The addition of this enzyme had very little effect 
on the survival of C  jejuni in UHT milk and the addition of an XO inhibitor (allopurinol) 
did not give rise to any enhancement in the survival of the organism suggesting that XO 
plays no role in influencing Campylobacter survival.
The similar properties of Helicobacter and Campylobacter made it worthwhile to compare 
the effect of LPO system in reconstituted UHT milk on the survival of H. pylori in 
comparison to C. jejuni. H  pylori was, however, found not to be sensitive to the LPO 
system and there were less than a 1 log reduction in bacterial viable counts after 9 h.
Camel’s milk is the most valuable of food resources for pastoral people in arid and semi- 
arid areas such as United Arab Emirates (UAE), Saudi Arabia, Mauritania, Kazakhstan and 
some other countries. Given the country of origin of the author of this study was UAE, this 
gave rise to unique opportunities to assess this milk for the presence of Campylobacter and 
for its lactoperoxidase activity. Of the 171 samples examined none tested positive for 
Campylobacter. Finally, the LPO system present in this type of milk did not have a 
pronounced effect on the survival of C. jejuni.
In conclusion, the results of this study suggest that Campylobacters are very sensitive to the 
LPO system, and that the pasteurization process does not fully destroy the presence of LP 
in milk. This inherent sensitivity means that pasteurized milk and the LPO system could be 
used to eliminate the presence of C. jejuni in various environments, particularly artificial 
surfaces.
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CHAPTER 1 
INTRODUCTION
1.1. History and Taxonomy of Campylobacter
For three decades, Campylobacter species have been known as a causative agent for a 
large number of animal and human infections. In 1913, McFadyean and Stockman first 
reported the involvement of pathogenic bacteria in the abortion of sheep and cattle. Due to 
the similar morphology of these bacteria with the genus Vibrio, it was first classified as 
Vibrio fetus (Smith and Taylor, 1919). It was not until 1947, when Campylobacter was 
cultured from human blood, that its potential significance in human disease was 
appreciated (Vinzent, et al., 1947). In 1963 it was first proposed by Sebald and Veron, that 
the genus Campylobacter (meaning a curved rod) which at this time contained only two 
species, Campylobacter fetus and Campylobacter bubulus (today known as Campylobacter 
sputorum). The main reason for this reclassification was that Vibrio fetus is different and 
unrelated to Vibrio spp. on the basis of its nucleotide base composition (G+C ratio is about 
35% whereas the G+C ratio in other vibrios it is approximatly 45%). Also, it neither 
ferments nor oxidizes carbohydrates, and therefore energy is derived from the degradation 
of tricarboxylic acid cycle intermediates or amino acids (Shane, 1992). In 1974, Smibert 
named the bacteria C. fetus and suggested three subspecies; C. fetus ssp. jejuni, C. fetus 
ssp. fetus, and C. fetus ssp. intestinalis. Campylobacter fetus ssp. jejuni was designated as 
C. jejuni and C  coli by the International Committee of Systematic Bacteriology (Skerman, 
et. al., 1980) and they are the main species associated with human gastrointestinal infection 
in the developed and developing countries (Alter and Schere, 2006). Reported cases of 
Campylobacter gastrointestinal infections have increased significantly and they are now 
recognized as important human pathogens. Their clinical impact has been broadly 
reviewed (Fenner, 1988). The isolation of Campylobacter was not successful until isolation 
procedures were developed by Dekeyser, et al., 1972 when he used filtration and culture 
on a blood-thioglycollate agar medium. In 1977, Skirrow developed a selective medium 
(blood based) that made the isolation more straightforward and exposed for the first time 
the true impact of these organisms (Skirrow, 1977). More modem media contain; 
bacitracin, polymyxin B sulfate, novobiocin and actidione as selective agents.
1.2. Epidemiology
Currently, of the 15 known species of Campylobacter, (C jejuni, C. coli, C. lari, C. 
upsaliensis, C. helveticus, C. fetus, C. hyointestinalis, C. mucosalis, C. concisus, C. curvus, 
C. showae, C, rectus, C. sputorum, C. bubulus and C. gracilis) C. jejuni and C. coli are 
responsible for over 95% reported cases of bacterial gastroenteritis in humans (Lastovica 
an Skirrow, 2000). In developing countries, the prevalence of Campylobacter infections is 
more likely to be in children less than one year old. In Southeast Asia, it causes 2.9% to 
15% of bacterial enteritis in children less than 5 years old (Padungton and Kaneene, 2003). 
The number of reported cases in developing countries could be largely underestimated due 
to failure to isolate Campylobacter. On the other hand, in developed countries, 
Campylobacter is recognized as the etiologic agent in many sporadic cases of 
gastroenteritis (Lehner, et. ah, 2000). The infection occurs in all age groups and rates peak 
in children less than 4 years old and in adults from 15 to 44 years old (Skirrow, 1987). First 
exposure to Campylobacter and undeveloped immunity are possibly reasons for the large 
rate of Campylobacter infection in infants. Mishandling practices with food could be 
responsible for the large number of campylobacteriosis cases seen in the adult age group 
(Altekruse, et. al., 1999). In England and Wales, it was reported by Public Health 
Laboratory Service Communicable Disease Surveillance Centre that the number of 
Campylobacter gastrointestinal infection disease is approximately 50,000 cases every year. 
However, the true number of cases was estimated to be eight times higher than what is 
reported because of under-reporting (Wheeler, et. al., 1999). In the United States, the 
estimated number of cases of Campylobacter infection is more than two million per annum 
(Skirrow and Blaser, 1992). A person with HIV is considered to be at higher risk of 
acquiring Campylobacter spp. and can be in danger of having an invasive disease due to 
immuno-deficiency (Butzler, 2004). It has been reported by Altekruse, that the incidence 
of campylobacteriosis in people with AIDS reached 519 cases per 100,000 and this rate is 
39 times higher than in the general population (Altekruse, et al, 1999). The frequency of 
infection by Campylobacter is found to be seasonal in moderate climates with the cases of 
infection reported in summer being twice as many as in winter (Butzler, 2004).
1.3. Character and Morphology
Campylobacter are gram negative, non-spore forming rods, spirally curved, slender (0.5 to 
5 pm long and 0.2 to 0.5 pm wide) (Figure 1). They have a characteristic corkscrew-like 
darting motility due to the polar flagellum at one or both ends of the cell (Uyttendaele, et. 
al., 2003). However, some may be non-motile (C. gracilis) or have multiple flagella (C. 
showae) (Nachamkin and Blaser, 2000).
Figure (1). Electron photomicrograph of Campylobacter jejuni undergoing division. (Picture 
courtesy by Dr. Mary Parker of the Institute of Food Research, Norwich, UK).
The organism shows gross morphological changes with time. In the exponential phase, the 
growing cells exhibit typical short spiral morphology, while, in mid-stationary phase the 
length of the same cells becomes twice the length of the exponential forms. In late 
stationary/death phase, a mixture of these two morphological shapes can be observed 
(Griffiths, 1993). In general, Campylobacter jejuni has two morphological forms; the spiral 
forms (culturable) and the coccoid form thought to be non-culturable. The coccoid form of 
Campylobacter can be generated by many environmental factors such as prolonged 
incubation of cultures, pH, temperature, osmolarity and lack of nutrients in the medium 
(Tangwatcharin, et. al., 2006).
Campylobacters being microaerophilic are optimally grown in atmospheres containing 5% 
O2  and 3-5 % CO2  (Altekruse, et. al., 1999). Although the organisms grow best at 42°C 
(Nachamkin, 1995), they do not grow below 30°C and survive poorly at room temperature 
(van de Giessen, et. al., 1996; Ketley, 1997). The viability of Campylobacter reduces
during frozen or chill storage, but it is still able to persist under these conditions for long 
periods as survival has been recorded in frozen poultry after several months of storage 
(Sampers, et. ah, 2010) and in milk and water at 4°C after several weeks (Blaser, et. ah, 
1980).
Two growth characteristics, the inability to grow below 30°C and the microaerophilic 
nature, limit the ability of Campylobacters to grow and multiply outside an animal host. 
Accordingly, these bacteria, unlike other food-borne pathogens, are unable to multiply 
during food processing or storage (Park, 2002).
1.4. Clinical Aspects
The most common symptom observed following Campylobacter infection is diarrhoea that 
can be limited to voluminous, and be watery in the beginning to bloody when the disease 
progresses, especially in children (Moore, et. ah, 2005). Other symptoms such as 
abdominal pain, fever, nausea (Humphrey, et. ah, 2007), headache, asthenia and anorexia, 
and muscle pain may also occur and may disappear before diarrhoea (Moore, et. ah, 2005), 
but vomiting is uncommon (Butzler, 2004). Generally, the incubation period for the 
infection is 1-10 days, but most people develop the clinical symptoms by 2 to 3 days after 
consumption of the contaminated food; and mostly the symptoms resolve themselves 
within a week (Humphrey, et. ah, 2007). Campylobacter might be excreted in the patient’s 
faeces for many weeks after the clinical symptoms have disappeared unless they are treated 
with antibiotics (Skirrow and Blaser, 2000). The infective dose of Campylobacter is very 
low; being as low as 500 cells up to 10,000 cells, depending on different factors such as 
bacterial strains, susceptibility of the host and the environmental stress (Bhavsar, et. ah, 
2004). Although C. jejuni infection primarily results in self-limiting diarrhoea, it can be 
more serious and life-threatening in some cases. Complication and long-term consequences 
of C. jejuni infection are Reiter’s syndrome, reactive arthritis, Guillain-Barre syndrome 
(GBS), Miller Fisher syndrome (Food-borne illness, 2005), meningitis (Herve, et. ah 
2004), abortions, cholecystitis (Landau, et. ah, 1995), transient bacteremia (Smally, et. ah,
1996) and urinary tract infections (Weber, 1982). Death due to Campylobacter infection is 
uncommon but may occur in immuno-compromised patients, infants and the elderly 
(Altekruse, et. ah, 1999). C. jejuni infection and Guillain-Barre syndrome have been
associated together in many cases. Approximately, 30-40 percent of GBS patients were 
infected and had suffered from a preceding infection with C. jejuni (McCarthy and 
Giesecke, 2001) and the symptoms of it present 1-3 weeks after the onset of 
Campylobacter enteritis (Butzler, 2004). GBS is an autoimmune disease which attacks the 
nervous system and causes progressive weakness and areflexia. In many countries this 
syndrome is known to be the most frequent cause of acute flaccid paralysis (Barzegar, et. 
ah, 2007). The cases of GBS correlated with Campylobacter infection are normally very 
acute and necessitate intensive care and treatment from the hospital as the severity of 
infection could cause a long-term disability (Butzler, 2004). The pathogenesis of GBS is 
due to molecular mimicry that is present among certain lipopolysaccharide (LPS) 
molecules of C. jejuni strains and human nerve tissue gangliosides 
(Takkinen and Ammon, 2003). Infection with Campylobacter induces gastroenteritis 
during which antibodies and T-cells are directed primarily against Campylobacter, leading 
to suppression of the organism. Due to significant molecular mimicry between the 
microbial antigens and self-antigens, the peripheral nerve cells are destroyed and this 
causes GBS (Butzler, 2004).
1.5. Pathogenesis of Campylobacter Infections in Humans
Even though Campylobacter has emerged as the major cause of Campylobacter 
gastrointestinal infection and bacterial food-borne diseases during the past decade the 
mechanism of disease production is still comparatively poorly understood (Ketley, 1997). 
Like other cases of food-home illness, the clinical outcome of Campylobacter infection is 
probably influenced by the host (age, health status and pre-existing immunity) and 
pathogen specific factors (Altekruse, et. al. 1999).
Since C. jejuni is a food-bome pathogen, it enters the host via the stomach acid barrier in 
association with food or water, and colonizes the distal ileum and colon (Ketley, 1997). 
After Campylobacter colonizes the mucous blanket and adheres to the intestine cell 
surface, the organism disturbs and interferes with the regular absorptive ability of the 
intestine by destroying the function of the epithelial cells directly by toxin production or by 
cell invasion, or indirectly through inducing host inflammatory reactions (Wooldridge and 
Ketley, 1996). Many pathogen-specific virulence determinants may contribute to the
pathogenesis of C. jejuni infection, but none yet has a proven role (Ketley, 1997). 
Suspected determinants of pathogenicity include chemotaxis, motility, and flagella, which 
are required for attachment and colonization of the gut epithelium. Once colonization 
occurs, other possible virulence determinants are iron acquisition, host cell invasion, toxin 
production, inflammation and active secretion, and epithelial cell disruption with leakage 
of serosal fluid (Wooldridge and Ketley, 1996).
1.5.1. Motility and Flagella
The spiral shape, rapid and darting motility character, which is due to the polar flagella of 
Campylobacters, was recognized as an important structure for the colonization of host cells 
and thus establishment of infection. The main structure of the flagellum consists of a hook, 
basal body and external filament, the latter is composed of two main subunits, a major 
flagellin (JlaA) and a minor flagellin {flaB). Both subunits share homology and are about 
59 kDa in size and expressed concomitantly. The JlaA gene is controlled by the sigma 
factor the classical promoter, whereas flaB  is controlled by dependent promoter 
(Guerry, et. al., 1991; Nuijten, et. al., 1990). Inactivation of the JlaA gene results in non- 
motile cells which express a truncated flagellar filament and these defined mutants are not 
able to adhere to and invade epithelial cells in vitro (Wassenaar, et. al., 1991). On the other 
hand, mutants in flaB  do not exhibit any significant change in motility and the production 
of the flagellar filament appears to be normal, as in the wild type (Gueny, et. al., 1991). In 
1993, a study by Nachamkin, reported that one of the flaA mutants was not able to produce 
any zone of growth on the motility agar, and a partial zone of about 11 mm in diameter 
was seen with the flaB  mutant using semisolid motility agar (Nachamkin, et. ah, 1993). In 
comparison the wild type produced a zone of growth with a diameter 30 mm after 48 h of 
incubation. In another study which assessed colonisation, inactivation of the flaB  gene, 
enhanced chicken caecal colonization 1000-fold and conversely, mutants with an 
inactivated flaA gene colonized 100- to 1000-fold less efficiently regardless of their 
motility conferred by truncated or full-length flagellin B flagella. This suggests that the 
presence of FlaA, rather than motility, is essential for optimal bacterial colonization of 
chicken caeca (Wassenaar, et. ah, 1993)
1.5.2. Chemotaxis
The significance of chemotaxis for pathogenesis has been established in C  jejuni (Takata, 
et. al., 1992). Chemotaxis is the phenomenon through which bacteria direct their 
movements toward certain chemicals and away from others which allows them to move 
towards favourable environments (Lux & Shi, 2004). Several investigators have found that 
mutant strains of C. jejuni lacking cheY, the key proteins of the chemotaxis pathway 
(chemotaxis sensors) was unable to colonize mice or cause disease in ferrets (Yao, el. al.,
1997). The mutant strains also showed straight swimming instead of chemotactic 
movement. It has been suggested that the sensor CheY in Campylobacter might interact 
with the flagellar motor and cause clockwise rotation, as was reported in Escherichia coli 
(Yao el. al., 1997; Foynes, et. al., 2000). It has also been shown that C. jejuni is strongly 
attracted toward various compounds such as L-fiicose, mucin, succinate, pyruvate and 
citrate; as well as certain amino acids, for example L-cysteine, L-glutamate and L- serine. 
Mucin is a complicated glycoprotein which may hold physiologically relevant 
oligosaccharide ligands for the adhesion of Campylobacter. It is also considered to be the 
major component of the gastrointestinal mucus, which gives this viscous layer its 
consistency (Hugdahl et. al., 1988). In 1992, Takata reported that three undefined mutant 
strains of C. jejuni did not display chemoattraction toward several known chemicals 
(Takata et. al., 1992). These were still able to swim and move but exhibited less frequent 
tumbling than the wild type strains. The mutant strains were also not able to colonize the 
intestinal tract of mice even when high concentrations of the organisms was used in 
comparison to the wild type, which exhibited penetration and colonization when as little as 
10^  cfu per mouse was used. The authors suggested that active motility mediated by the 
flagella and chemotactic movement is very important factor for colonization of the mouse 
intestinal tract by C. jejuni. However, the signal receptors and molecular basis of the 
chemotactic response in C. jejuni is still poorly understood (Takata et. al., 1992).
1.5.3. Adhesion
Adhesion is thought to be one of the key virulence factors for C. jejuni infection and is 
considered to be the primary step of bacterial-intestinal cell interaction (Konkel and Joens, 
1989; Prasad et. al., 1991). Adhesion to and invasion of human epithelial cells and 
intestinal mucous gel are important phenomena in the pathogenesis of Campylobacter 
infection (de Melo, et. al., 1989). Many studies have shown that clinical isolates adhere to 
a variety of human cell-types in vitro (Konkel and Joens, 1989; Kervella et. al., 1993). 
Additionally, Newell and Pearson used scanning electron microscopy to prove in vitro 
adherence of C. jejuni to intestinal epithelial cells and noted that adhesion could be 
mediated by flagella (Newell and Pearson, 1982). Moreover, the same group reported that 
flagellated organisms adhered in greater numbers to cells than aflagellated variants 
(Newell et. al., 1983).
Adhesins are the surface exposed molecules responsible for the attachment of pathogens to 
host cell receptor molecules. Strains of Campylobacter jejuni have the ability to adhere to 
both the HEp-2 and HeLa cells (Prasad et. al., 1996). C. jejuni also has the binding 
capability to cells of non-human origin (Vero, CHO-Kl and MDCK). The binding of C. 
jejuni to human Henle, human intestinal epithelial cell line (INT407) cells and human 
colonic cell line (Caco-2) cells are thought to be more representative for infection of those 
cells that C. jejuni encounters in vivo (Konkel and Cieplak, 1992).
several C. jejuni structures (flagella, LPS and proteins) are believed to be involved in 
adherence (Grant, et. al., 1993). However, the best characterized proteins that may be 
involved in adherence are the PEBs which were named after the investigators that first 
identified them (Pei, Ellison and Blaser). In 1990, de Melo and Pechere identified C. jejuni 
surface proteins which adhered to eukaryotic cells in vitro (Kuusella, et. al., 1989). Two of 
these proteins with apparent molecular masses of 28 kDa and 32 kDa were later identified 
as PEBs. Fauchere et. al., (1992) also identified two proteins in cell binding fractions 
(CFBs) with apparent molecular masses of 27 kDa (CFBl) and 29 kDa (CFB2) (Mantle 
and Husar, 1993). CFBl and CFB2 were later shown to be PEBl and PEB4 respectively 
(Goldfme, 1982).
Konkel et al, (1997) have identified CadF, as a 37-KDa fibronectin-binding protein. 
Campylobacter adhesion to fibronectin (CadF), is considered to be similar to outer
membrane protein A of E.coli, and is required by C. jejuni for maximal adherence and 
invasion at the basolateral surface of intestinal epithelial cells (Monteville & Konkel, 2002; 
Monteville et a l, 2003). A study by Ziprin demonstrated that the CadF protein is required 
by C. jejuni for the colonization of chickens (Ziprin et al., 1999).
Other well-characterized outer membrane proteins in Gram-negative bacteria include the 
autotransporter systems. Following export from the cytoplasm to the periplasm via the 
general secretory system (Sec), autotransporter translocation domains insert into the outer 
membrane as (3-barrel structures and here mediate the export of virulence proteins. The 
exported protein may either remain attached to the outer membrane or can be released in a 
free state and may serve as adhesins, hemolysins, proteases, cytotoxins, or mediators of 
intracytoplasmic actin-promoted bacterial motility (Kim et. al., 2006) CapA is an 
autotransporter found in C. jejuni which is believed to be retained on the cell surface. A 
mutant deficient in CapA was reported to have reduced ability to associate with and invade 
Caco-2 cells m vitro (Ashgar et a l, 2007) and thus is a possible adhesin. Lastly, a 
periplasmic glycoprotein, encoded by Cj 1496c, has been shown to mediate C. jejuni 
invasion of human epithelial cells (Kakuda & DiRita, 2006). Other putative adhesins 
include a collagen-binding surface protein such as SpaP. This outer membrane adhesin 
believed to be involved in iron acquisition and a putative periplasmic adhesion. It is also 
believed to function as receptors for an ABC transporter for metal ions (Fouts et a l, 2005; 
Gundogdu et a l, 2007).
1.5.4. Invasion
The study of inflammation markers that occur during infection has resulted in a remarkable 
proposal. The proposal is that invasion of the epithelial host cells by Campylobacter can 
cause triggers inflammation (Everest et. a l, 1993). Host cell invasion has been studied 
extensively in vitro using several different cell lines and invasion has been shown to be 
dependent on newly synthesised Campylobacter proteins and host cell signal transduction 
(Konkel, et. a l, 1993). Campylobacter also synthesizes a set of proteins during co-culture 
with epithelial cells, a subset of which are secreted. The secreted protein Campylobacter 
invasion antigen (Cia) plays a role in the colonization of chicken gut. Secreted proteins 
were also recognized by Western immunoblot using sera from birds that had been 
colonised by C. jejuni. These data suggest that C. jejuni secretes proteins during
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colonisation of chicken gut and that these Cia proteins play an important role in 
colonization (Konkel et. al., 2004, Biswas et. al., 2007)
1.5.5. Toxins
The production of toxins may also play role in Campylobacter virulence, the 
characterization of toxin production by Campylobacter spp. has been a slow process. Many 
researchers reported the production of several toxins by Campylobacter, but their role in 
disease and their mechanisms of action have never been confirmed (Wassenaar, 1999). For 
many years there was conflicting evidence as to whether Campylobacters produced a 
cholera-like enterotoxin (CLT) and other cytotoxins (McCardell, et. al., 1984; Johnson and 
Lior, 1987). However, when the genome of C. jejuni was first sequenced (Parkhill, et. al., 
2000) the only toxin apparent was the cytolethal distending toxin (CDT) (Mooney, et. al., 
2001; Johnson and Lior, 1988). CDT is not only produced by C. jejuni but is also made by 
other diarrhoeagenic bacterial species such as C. coli and C. fetus (Johnson and Lior, 1988; 
Pickett, et. al., 1996) as well as by some strains of Escherichia coli (Johnson and Lior, 
1988) and Shigella spp. (Johnson and Lior, 1987). Although, the exact function of CDT 
proteins are unknown, for E. coli CDT causes blockage in either G2 or early M phase of 
the cell cycle before cell division for many different cell types (Whitehouse, et. al., 1998; 
Peres, et. al., 1997). The CDT produced by Campylobacter spp, causes a progressive 
cellular distension of the host cell and HeLa cells to accumulate the inactive, 
phosphorylated form of CDC2 .Therefore, the cell becomes quickly and irreversibly 
blocked in the G2 phase of the cell cycle (Whitehouse, et. al., 1998). This shows that the 
action of CDT toxin varies from that of other bacterial toxins (Whitehouse, et. ah, 1998; 
Pickett and Whitehouse, 1999).
C. jejuni CDT is encoded by three adjacent genes, including cdtA, cdtB and cdtC. The 
CdtB subunit is proposed to be the most conserved component of the holotoxin amongst all 
the CDT-producing bacteria. CdtB, is the active component of the toxin and has been 
shown to possess DNAase activity and be responsible for the observed morphological 
changes, with CdtA and CdtC being needed for delivery (Lara-Tejero and Galan, 2001). In 
2001, it has been found that cdt gene occurs in both C. jejuni and C. coli isolates from 
broilers (Bang, et. al., 2001). Although these two species of Campylobacter are closely 
related, there are distinct differences in CDT production (Bang, et. al., 2001). Despite
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having a well established function in vitro, the role that CDT plays during infection is still 
not clear. A study by Abuoun, (2005) on a patient with disease symptoms showed that 
neutralizing antibodies were elicited against the toxin in humans, but not in 
asymptomatically colonised chickens. This study suggests that the function and the role of 
toxin may only be relevant to human infection. The isolation of naturally occurring Cdt- 
negative strains, albeit rarely, from symptomatic cases of human infection would suggest 
however, that is not an essential virulence factor (Abuoun, et. aï., 2005).
1.5.6. Lipopolysaccharide (LPS)
Lipo-oligosaccharides (LOS) and LPS are major constituents of the outer membrane of 
Gram-negative bacteria which contribute greatly to the structural integrity of this 
membrane, and protect the cell against a variety of stresses. It comprises three parts: the O 
antigen, the core oligosaccharide and Lipid A (Aspinall, et. al., 1993). In certain bacteria, 
such as Neisseria, LPS is distinguished from that of other bacteria by its highly-branched 
basal oligosaccharide structure and the absence of repeating O-antigen subunits. For these 
reasons, this LPS is referred to as lipooligosaccharide (LOS) (Griffiss, 1995)
The LPS of the family Enterobacteriaceae and Campylobacter, consists of lipid A, core 
oligosaccharide, and 0-polysaccharide chains. Typical members of this family such as 
Salmonella with a single core and Escherichia coli with five core regions exhibit more 
conserved core oligosaccharide regions in their LPS (Aspinall, et. al., 1993). Although 
LPS molecules are larger, LOS has been shown to be more structurally and antigenically 
diverse than LPS (Griffiss, 1995). Lipid A is comparable in structure and composition 
among the family Enterobacteriaceae (Perez-Perez, et. al, 1986). The LPS of 
Campylobacters share lipid A antigenic determinants with core regions of LPS from several 
other gram-negative organisms (Perez-Perez, et. al., 1986). The LPS of Campylobacter is 
also antigenically diverse resulting in a large number of serotypes (Walker, et. al., 1986). 
This observation has proven to be very useful in the heat stable serotyping scheme of 
Penner and Hennessy (1980). However, unlike other enteric bacteria, C. jejuni has LPS 
rich in sialiated glycans. This may be a mechanism for inhibiting antibody binding by the 
unusual sialylation of LPS or it may increase the antigenic variability of LPS (Newell and 
Nachamkin, 1992).
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Analysis of the LPS from C. jejuni isolates from two siblings with GBS demonstrated that 
LPS possessed the same O-chain structures linked to core oligosaccharides with different 
molecular weights (Aspinall, et. al., 1994). The study demonstrated ladder-like bands of 
similar periodicity but with slightly different mobilities on SDS-PAGE. These results 
suggested that identical O-chain may be linked to different core regions. Additionally, the 
C. jejuni core regions have been shown to mimic human glycosphingolipids. The 
molecular mimicry and the structural variability of the C. jejuni core oligosaccharide 
suggest that C. jejuni's LPS is similar to lipooligosaccharide LOS (Aspinall, et. al., 1994; 
Aspinall, et. al., 1993). Initially it was believed that C. jejuni LPS possessed adhesive 
properties. However, Moser and Hellmann reported that LPS did not have significant 
adhesive properties (Moser and Hellmann, 1989). They later showed that LPS-specific 
monoclonal antibodies could not inhibit binding, although LPS binding was detected with 
the antibodies, indicating that LPS is associated with, but is not a binding structure (Moser, 
et. ah, 1992).
1.5.7. Oxidative stress
Generally, C. jejuni cells will be exposed to oxidative stress in their natural environments. 
However, Campylobacters are microaerophillic implying an inherent sensitivity towards 
oxygen and its reduction products (Park, 2002).
The main defence against oxidative stress in Campylobacters is superoxide dismutase 
(SodB). C. jejuni has been shown to possess a gene encoding a 25 kDa superoxide 
dismutase (SOD) protein which plays a key protective role against oxidative damage 
(Pesci, et. al., 1994). The sodB gene encodes a SOD most similar to those containing iron 
cofactors (FeSODs) so it was named SodB. Whilst C. jejuni produced at least 5 
electrophoretically distinct bands of SOD activity; these all disappeared when a sodB 
mutant was assayed and it is believed that the sodB gene is the only sod gene that C. jejuni 
contains (Purdy et al, 1999). The enzyme has been found to be important for C. jejuni 
survival in INT 407 cells (Pesci et. al., 1994), in air and model food systems (Purdy, et. ah, 
1999). In addition, SodB activity was found to be necessary for the efficient colonisation of 
chicks (Purdy, et. a l, 1999).
12
The other main oxidative stress defence mechanism is involved in the defence against 
peroxides. A gene encoding catalase activity known as KatA was cloned and sequenced 
(Grant and Park, 1995). Another evidence suggests that KatA is structurally and 
enzymatically similar to the hydrogen-peroxidases characterised in other bacterial species. 
A katA mutant was more sensitive to killing by hydrogen peroxide suggesting that this 
enzyme is important in the detoxification of this compound (Grant and Park 1995). 
Superoxide dismutase and catalase activity allow C. jejuni to survive in the aerobic 
environment and activities may also assist in survival during macrophage burst 
encountered during infection (Pesci et al., 1994).
Nitric oxide (NO) and its byproducts such as peroxynitrite have strong bactericidal effects 
and serve as one of the host cell defence mechanisms against microbial infection especially 
in the intestine (Elvers, et. al., 2004). To avoid this nitrosative stress, C. jejuni can activate 
gene expression from a small regulon under the control of the NO-sensitive regulator 
known as NssR. This operon encodes two haemoglobins Cgb and Ctb (Monk, et. ah, 
2008). A Cgb deficient mutant of C. jejuni was hypersensitive to nitrosating agents such as 
S-nitrosoglutathione (GSNO) and a nitric oxide-releasing compound such as spermine 
NONOate indicating the key role of Cgb in nitrosative stress resistance (Elvers, et. ah,
2004).
1.6. Sources of Infection and Mode of Transmission
C. jejuni is considered to be a zoonotic organism that lives as a commensal in many 
domestic and wild animals such as birds, chickens, turkeys, quails, ducks, ostriches, sheep, 
pigs, cattle, and pets (Newell and Feamley, 2003; Moore, 1999). Campylobacteriosis is a 
food-borne disease (Altekruse, et. ah, 1999). The foods of animal origin such as poultry 
and raw milk play a major role in infection. In general, raw meat which is bred for 
consumption possibly will be contaminated with Campylobacter (Butzler, 2004). All parts 
of poultry carcasses and poultry products have been implicated in the transmission of 
Campylobacter. When Campylobacter carriage in chicken flocks is determined, the 
organism is usually isolated in large numbers from the majority of birds sampled (Stem, 
1992). Retail chickens display contamination rates between 60-80%, with Campylobacter 
counts in the range of 10  ^ per fresh chicken carcass (100 fold lower in frozen birds)
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(Skirrow and Blaser, 1992). Although Campylobacter is excreted in chicken faeces, the 
organism is not vertically transmitted through the egg (Stem, 1992). Young chickens, in 
commercial production, remain free of Campylobacter for several weeks but eventually all 
become colonized in the caecum (Stem, 1992). Study conducted by European Food Safety 
Authority (EFSA, 2008), on prevalence of Campylobacter on batches of broiler chickens in 
26 EU participating Member State and two non-Member State showed that Campylobacter 
was detected on broiler carcasses in all participating community. The prevalence of the 
Campylobacter-coXomsQà. broiler batches was 71.2% and in Campylobacter-coxiXeirmviatQ& 
broiler carcasses was 75.8%. Most of the isolates were identified as C. jejuni and C. coli. 
Prevalence of Campylobacter-coXoNistà^ broiler batches ranged from a minimum of 2.0% 
in Estonia to a maximum of 100.0% in Luxembourg. The median of prevalence was 57.1% 
in Italy, Czech Republic and Switzerland (EFSA, 2008)
Some activities such as barbecues are thought to pose a special risk due to the ease of 
transfer of the organism from raw meat to people’s hands, then to other foods and finally 
from hands to the mouth (Butzler, 2004). Transmission of C  jejuni fi’om person to person 
is uncommon (Robinson, 1981), but reports of nosocomial spread, intrafamilial clusters, 
and infections in neonates whose mothers had positive cultures suggest that it may occur 
(Kapperud, et. al., 1992).
Carrier animals have also been found to be a source of C. jejuni infection (Adak, et. al., 
1995). The presence of puppies and kittens in a household is more likely to cause clinical 
campylobacteriosis in children than adults (Tenkate and Stafford, 2001; Hald and Madsen, 
1997). In the late 1980s and early 1990s many reports suggested that C. upsaliensis may be 
a human food-borne pathogen which in some cases might cause septicaemia. Since this 
organism is frequently found in cats and dogs (28 to 82%) (Aspinall, et. al., 1995; 
Lastovica, et. al., 1989), much interest has developed in these two companion animals with 
respect to the epidemiology of C. upsaliensis infection (Hald and Madsen, 1997).
Untreated water and drinking water are also considered to be significant sources of 
massive outbreaks of Campylobacter infection (Butzler, 2004). About 20% of 
gastrointestinal cases are thought to be caused by water-borne C. jejuni (Mead, et. al., 
1999). These are more likely in spring or/and early autumn, due to the seasonality of 
infection in cattle herds and their contamination of surface waters (Tauxe, 1992). The 
Public Health Laboratory Service and Communicable Disease Surveillance Centre (PHLS- 
CDSC) in England and Wales reported 26 outbreaks from water-borne pathogens between
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1992 and 1995; Campylobacter was responsible for 10 outbreaks associated with private 
water supplies (Furtado, et. al., 1998). Campylobacter is naturally present in streams, 
rivers, and lakes due to discharges from wastewater treatment plants, direct contamination 
by faeces of birds and animals and runoff from agricultural lands (Padungton and Kaneene,
2003). However, the survival of Campylobacters in the environment depends on a number 
of factors, such as temperature, oxygen, nutrients and pH (Padungton and Kaneene, 2003).
Consumption of raw milk is also acknowledged as an important vehicle for transmission 
of C. jejuni (Robinson, 1981). The first human outbreak of campylobacteriosis was 
reported in May 1938, which concerned 357 prison inmates sickened by consumption of 
contaminated milk (Motarjemi and Adams, 2006). In Great Britain, fourteen milk- 
associated outbreaks were reported before the 1980s and these included more than 4000 
people (Robinson, 1981). In the United States, 14 outbreaks were reported during the 
period 1980-1982 in which many children were involved (Evans, et. al., 1996). As this 
organism is present in the intestinal tract of dairy animals, the milk normally will be 
contaminated during milking as a result of faecal contamination or due to improper 
washing of udders. Although pasteurization will kill Campylobacters in milk, many milk- 
associated outbreaks have been occurred and been correlated with the consumption of raw 
milk, contamination with raw milk or inadequate pasteurization (Humphrey, et. al., 2007).
1.7. Helicobacter pylori
A spiral shaped bacterium with similar morphology to Campylobacter was first mentioned 
by Bizzozero, 1893, in samples from the mammalian stomach. A few years after, 
researchers described the appearance of an identically shaped bacterium in human gastric 
lesions and necrotic material at the surface of ulcerating carcinomas (Krienitz, 1906; 
Luger, 1917). Only much more recently, in 1975, was this organism described again, when 
Steer found it in a patient with a gastric ulcer where it was present on the surface of 
epithelial cells (Steer, 1975). The role of this organism was only fully appreciated when 
two researchers from Australia were able to grow this spiral Campylobacter-UkQ bacterium 
colonizing human stomach, and related it to peptic ulcer disease (Marshall & Warren, 
1983; Marshall, 1989). The bacteria were named initially as Campylobacter pyloridis, but 
the name changed soon after to C. pylori due to the former being grammatically inaccurate
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(Marshall, et. al., 1984 and Marshall, & Goodwin, 1987). Taxonomically the organism was 
different from other Campylobacter species on the basis of cellular fatty acid, ultra­
structure features, DNA hybridization, analysis of respiratory quinones, growth 
requirement and susceptibilities to antibiotics, and this led microbiologists to create a new 
genus, Helicobacter due to the helical morphology in vivo, though this is often rod-like in 
vitro (Goodwin, et. al., 1989).
1.8. Epidemiology
Helicobacter pylori is a human pathogen, that is known as the main cause of chronic 
gastritis, peptic ulcers and gastroduodenal ulceration, and it is also involved in the 
development of gastric cancer and lymphoma of the stomach (Fan, et. al., 1996). Two 
types of antimicrobial therapy are used normally for treating such cases, a combination of 
antibiotics with a proton-pump inhibitor, and bismuth with antibiotics. Vaccines have not 
yet been developed for human use (Scott, et. al., 1998; Eaton, et. al., 1998). A total of 17 
species of Helicobacter have been reported, and of these, seven of them were found to be 
associated with the gastric mucosa of many mammalian species. The other 10 species are 
mainly associated with the intestinal mucosa (Farthing, 1998). These bacteria colonize the 
stomach at some stage in childhood and stay for years in the host without exhibiting any 
clinical symptoms except for a chronic inflammation of the gastric mucosa (Owen, 1995). 
The mode of transmission is generally thought to be vertical within families via either oral- 
oral or faecal-oral routes. The latter route is considered to be more important than the 
former in the developing world due to indirect interpersonal contact, and environmental 
contamination (Sahay & Axon, 1996). Here, lack of sanitation, polluted water, and milk 
contaminated with unclean water, or eating raw vegetables that have been irrigated with 
contaminated water by human excrement are believed to be responsible for the infection 
with H. pylori. Communal eating habits and parental practice of chewing food for their 
children are considered to be the main oral-oral route for the infection with this organism 
in undeveloped countries (Sahay & Axon, 1996). Thus, a high prevalence of about 90% of 
people is infected in these developing countries, whilst up to 50% of adults are reported to 
be infected in industrialized countries (Farthing, 1998; Bardhan, 1997).
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1.9. Character
H. pylori is a gram negative (oxidase positive) bacterium, non-spore forming an S-shape or 
curved rod. The width ranges between 0.5 -  0.9 pm and length is 2 -  4 pm. The bacterial 
cells are mainly actively motile due to their multiple unipolar sheathed flagella. 
Occasionally, the cells form spherical, V- shaped, U- shaped and straightened forms. H. 
pylori is microaerophilic requiring reduced levels of oxygen (5%), a high level of CO2 , a 
high level of humidity (69 -  100%) and a pH of around 7.0 (Owen, 1995). Although, the 
growth of bacteria at 25°C is not possible, it grows optimally at 30°C and 37°C with 
changeable growth at 42°C (Owen, 1995). There are various confirmatory tests that can be 
used to characterize the bacterium in the laboratory such as the urease test, catalase and 
oxidase test, production of H2 S gas when triple sugar iron agar is used, nitrate reduction, 
susceptibility to metronidazole and cephalothin, resistance to nalidixic acid and the 
hippurate hydrolysis test (Goodwin, et. al., 1989). Originally, it was believed that H. pylori 
was not able to ferment carbohydrates (Tee, eA ah, 1991), but more recently, researchers 
found that the bacteria could not only catabolise polysaccharides but also transport and 
convert D-glucose into lactate depending on the strain and growth conditions. Although the 
glucose is not important for the growth of the organism, it is an abundant substrate in 
human hosts (Mendz & Hazell, 1993).
Various studies have been conducted to evaluate the best media for the recovery of H. 
pylori. Most of them use a blood supplement (Sjostrom & Larsson, 1996). Brain Heart 
Infusion Broth (BHIB) was reported to be the best liquid medium and kept H. pylori viable 
for 3 days at temperatures ranging from -4°C to 21°C when supplemented with 10% horse 
serum (Xia, et. ah, 1993). A study by Hachem (1995) showed that Brain Heart Infusion 
Agar (BHIA) supplemented with 7% fi*esh whole, defibrinated horse blood was suitable for 
the isolation of H.pylori fi*om gastric mucosal biopsy samples, particularly when fi-esh 
media and adequate humidity were used during incubation (Hachem, et. ah, 1995). Out of 
several media, Wilkins-Chalgren agar supplemented with 5% horse serum was found to 
perform best in recovery tests of H. pylori from food samples. Horse serum gives rise to 
recovery similar to that measured with blood supplementation and has a longer shelf life 
and a lower cost (Poms, 1997).
17
1.10. Pathogenesis of infection
Although H. pylori has emerged as the major cause of gastric inflammation and a 
significant amount of the world’s population have been infected, the exact mechanism of 
disease production is still relatively unclear. But some factors and genes have been found 
and defined that could play an important role in the pathogenesis and colonization (Owen, 
1995). Virulence factors that have been proposed include motility, adhesion, cytotoxins, 
and urease activity (Fumarola, et. al., 1992).
The presence of five sheathed flagella that are located at one pole and the spiral shape of
H. pylori together allow it to penetrate and move through the stomach mucous layer and to 
colonize the underlying gastric epithelium (Lee, et. ah, 1993). A study by Josenhans, et. 
ah, (1995) reported that removal of flagella, encoded by the flaA and jlaB  genes resulted in 
non-motile bacteria. When these mutants were assessed in a piglet model they were not 
able to penetrate and colonize the piglets as fast as the wild type strain (10"^  fold lower) 
(Eaton, el. ah, 1996). Mutation of one of the flagella genes, either yZaT or flaB  resulted in 
partial motility and cells that could colonise but at a much slower rate, suggesting that 
although partial motility can allow some colonization, the presence of both genes as in 
wild type is important for H. pylori to achieve high level of infection in the piglet 
(Ottemann & Lowenthal, 2002).
During infection, about 20% of H. pylori adhere to the mucosal epithelial cells via 
pedestals, and the rest of cells live freely in the stomach mucous of the infected host. 
Gastric biopsies samples show H. pylori in various places such as, within and under the 
mucus layer, near the surface to the gastric epithelial cells, attached to the gastric cells and 
sometimes in the mucus secretion and this indicates that the adherence of H. pylori to the 
mucus layer lining of the stomach epithelium is important for the induction of 
inflammation (Segal, et. al., 1996). The production of adhesin is involved in binding the 
organism to membrane-associated lipids and carbohydrates, and helps the bacterium to 
adhere to epithelial cells. Various types of H. pylori adhesins have been identified and 
studied in their relation to bacterial pathogenesis.
For example, the well characterized adhesins, BabA and SabA, bind to the fucosylate 
Lewis B blood group antigen and sialyl-dimeric-Lewis x glycosphingolipid on the gastric 
epithelial surfaces, respectively (Mahdavi, et. al, 2002). Some studies found that strains of
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H. pylori that express low levels of BabA contribute to more severe mucosal injury, and 
also were more associated with gastric cancer and duodenal ulcer than strains expressing 
higher levels of BabA or even the one that lacking the babA gene (Fujimoto, et. al., 2007).
Some strains of Helicobacter such as H. felis and “G. hominis'' do not require adherence 
in order to colonize gastric epithelial cells and simply colonize mucus, and due to their 
high motility, they stay within the gastric mucosa (Lee, et. ah, 1989).
About 50% of all H. pylori strains produce and secrete a vacuolating cytotoxin due to the 
presence of VacA genes (Suerbaum and Michetti, 2002). This is an extremely 
immunogenic protein which induces a huge amount of vacuolization in epithelial cells. The 
function of this protein is to target the mitochondrial membrane and the cell membrane, 
where it forms an anion-selective and voltage-gated channel (Tombola, 2000). Moreover, 
the VacA channel releases cytosolic bicarbonate, organic anions and mitochondrial 
cytochrome c to induce apoptosis and thus raise the turnover rate of gastric epithelium 
(Lehmann, et. al., 2002; Galmiche, et. al., 2000). Studies have reported that strains of H  
pylori that are VacA positive have a growth advantage in vivo, , though VacA is not 
important for the growth and survival of H. pylori in vitro and has no effect on gastric 
inflammation (Salama, et. ah, 2001). Although, both VacA positive and VacA negative H. 
pylori strains have been isolated from humans, the VacA positive strains are considered to 
be more virulent and are more commonly associated with complications with the disease 
state in the European population. The same association was not seen in Asian regions 
(Xiang, et. al., 1995; Atherton, et. al., 1997).
VacA strains have been reported to penetrate into deeper tissues and here it may interact 
with many related cells such as monocytes, T-cells, B-cells and granulocytes. In 
association with these immune cells; VacA inhibits the recognition of antigens and blocks 
the production of T-cells by inducing G 1/S cell cycle arrest and therefore results in down- 
regulation of IL-2 transcription (Gebert, et. al., 2003), suggesting that the H. pylori VacA 
positive strains evade host immune response and may reduce H. pylori associated gastric 
inflammation.
Almost all strains of H. pylori produce urease enzyme which is found to be the most 
important and necessary factor for the start of chronic infection. Studies have identified 
two major subunits related to this enzyme and they are encoded by two chromosomal 
genes ureA and ureB. The function of this enzyme is to break down the urea, which is
19
normally secreted into the stomach, to hydrogen carbonate and ammonia. The latter is 
converted to ammonium after taking a proton (H^) from water and that leaves only the 
hydroxyl ion. The produced hydroxyl ion then reacts with the hydrogen carbonate, 
achieving a local neutralization of the gastric acid via the end product of the reaction, 
bicarbonate (Tanahashi, et. al., 2000; Peek, 2005; Suarez, et. al., 2006). Therefore, H. 
pylori can survive for some time in the acidic environment of the gastric lumen which is 
pH 1-2, before moving or penetrating into the bicarbonate-buffered mucus layer of the 
stomach mucosa (Benanti & Chivers, 2009). A study carried out in rodent models showed 
that strains of H. pylori which do not produce urease enzyme failed to colonize the 
stomach, suggesting the importance of the this enzyme for host colonization.
1.11. Milk
Milk is a complex biological fluid, and excluding colostrums, is secreted by mammals for 
the nourishment of their young (Adams & Moss, 2008). The main elements of milk are 
water, fat, proteins and lactose which vary according to species (Adams & Moss, 2008). 
Vitamins and minerals, antimicrobial factors and hormones are also present in milk 
(Silanikove et. al, 2006). The lipid in the milk is present in the form of fat globules, which 
is spread in milk as small droplets and enveloped by a plasma membrane normally known 
as the milk fat globule membrane (MFGM) (Silanikove et. al, 2006). The protein systems 
in milk can be divided into two main families: insoluble casein proteins (represent 80% of 
the total protein of milk) and soluble whey proteins (serum proteins) (Madureira, et. al, 
2007). The latter comprise small quantities of the blood-derived proteins such as 
immunoglobulins (IG) and serum albumin and globular proteins, p-lactoglobulin (P-LG) & 
a-lactalbumin (a-LA) (Adams & Moss, 2008) and many enzymes such as lysozyme, 
lactoferrin, catalase, lactoperoxidase and xanthine oxidase (Madureira, et. al, 2007). Some 
of these enzymes have been found to have an obvious physiological role such as an 
antimicrobial activity. Around 70 indigenous enzymes have been reported in bovine milk 
and the main source of them include blood plasma, somatic cells (leucocytes), secretory 
cell cytoplasm and MFGM (Fox & Kelly, 2006).
Raw milk from a healthy cow normally contains low numbers of bacteria; less than 100- 
1000 cfii/ml and on some occasions may be sterile. However, with mastitis, an
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inflammatory disease of the mammary tissue of the cow, the bacterial count increases and 
could exceed 10  ^cfu/ml (Adams & Moss, 2008). Milk is known to be an excellent growth 
medium for micro-organisms especially when combined with a suitable temperature. 
Contamination in milk can occur easily from variety of sources leading to its early spoilage 
(Chatterjee, et. al., 2006), this includes from the udder interior, teat exterior, from surface 
of equipment used for milk handling and storage processes (Adams & Moss, 2008). There 
are several types of bacteria encountered in milk depending on their heat resistance and 
optimum temperature for growth; psychrotrophic bacteria that are mainly involved in 
spoilage due to some being heat stable such as Pseudomonas fluorescens and 
Pseudomonas fragi', mesophilic bacteria and thermoduric bacteria such as Bacillus, 
Clostridium, Lactobacillus and Streptococcus that can grow at refrigeration temperatures 
and survive pasteurization and can be a source of spoilage (Goff, 2007). High numbers of 
bacteria >100,000 cfu/ml is an indication of poor quality of raw milk and is evidence of 
serious problems in production hygiene (Robinson, 1990). Human pathogenic bacteria can 
also contaminate raw milk and cause serious food-borne disease if the milk does not go 
through a proper pasteurization process. These pathogens are Salmonella species. Listeria 
monocytogenes, Escherichia coli. Staphylococcus aureus, Campylobacter jejuni. Bacillus 
cereus, Mycobacterium tuberculosis and M. bovis all of which can be transmitted through 
milk (Robinson, 1990). To reduce and prevent contamination from the outside udder, 
several measures can be taken; proper cleaning of milk-handling equipments (teat cups, 
pipe-work, milk holder and storage tanks), keeping a clean environment surrounding the 
animal (bedding and parlour floor) (Adams & Moss, 2008).
To reduce the number of bacteria, prolong the shelf-life and to ensure good biological 
quality, milk can undergo many processes from the time of collection in bulk tank until 
transported to the dairy. These approved preservation methods include; refrigeration, heat 
treatment (pasteurization and sterilization) and high pressure treatment (FAO & WHO,
2005). Pasteurization is considered to be the most effective method for destroying the 
vegetative microbial pathogens that are a safety concern (Vamam and Sutherland, 1994). 
There are two common types of pasteurization techniques used for milk nowadays; Low 
Temperature Long Time (LTLT) which involves heating the milk to 62.5°C for 30 min, 
and the High Temperature Short Time (HTST) pasteurisation, that involves heating the 
milk faster and to a higher temperature 72°C for 15 sec (Grant, et. al. 2005). Pasteurization 
is defined by The International Dairy Federation (IDF) as “A process applied to a product
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with the object of minimizing possible health hazards arising from pathogenic micro­
organisms associated with milk, by heat treatment, which is consistent with minimal 
chemical, physical and organoleptic change in the product” (Varnam and Sutherland,
1994). After pasteurization milk should be held and kept cold under refrigeration at 4°C all 
the time during storage and transportation to stop the growth of many micro-organisms; 
however any remaining psychrotrophic bacteria are able to grow and survive at this 
temperature (Doyle and Beuchat, 2007). Cooling is considered to be the most commonly 
used method to prevent or delay the deterioration of milk on its way from the farmer to the 
dairy (Claesson, 1992). However, this method is not always possible in many parts of the 
world due to reasons such as high operational costs, lack of available capital, less 
developed road systems, lack of electricity and frequent breakdowns of equipment with 
lack of spare parts especially in rural areas. The high ambient temperatures in these areas 
complicate the problem of milk collection. Therefore, fresh milk spoils readily causing 
considerable economic loss, and in several parts of the world only a small amount of the 
milk reaches the dairy industries in an acceptable condition for use as human food 
(FAO/WHO, 2005). Research into ways that may provide an alternative to refi'igeration 
has been ongoing. The FAO and WHO strongly discourages the use of chemicals in milk 
preservation, except the application of H2 O2  and the native lactoperoxidase system 
(Masud, et. al., 2010), but the use of hydrogen peroxide has failed to become an acceptable 
means of preservation due to toxicological aspects and the difficulty in controlling its 
application (must be completely destroyed before consumption either by heat treatment or 
by means of catalase) (Ozer, et. al., 2003). Therefore, the main alternative method to 
improve the quality and storage of milk in areas where it is not possible to use mechanical 
cooling for technical and economic reasons relies upon naturally occurring antibacterial 
systems in milk such as the lactoperoxidase system (Claesson, 1992; FAO, 1992).
1.11.1. Camel’s milk
The dromedary camel {Camelus dromedaries, the one-humped camel) is the most 
important livestock animal in the semi-arid areas of Northern and Eastern Africa as well as 
in the deserts of the Arabian Peninsula. It is a multipurpose animal, used for its supply of 
milk, meat, hides and transport (Rappeler, 1999)
22
Camel milk is one of the most valuable food resources for pastoral people in arid and semi- 
arid areas. In recent years, the consumption of camel milk among urban populations has 
increased (El-Ziney and Turki, 2007; Farah, 2004) but there are still countries such as the 
United Arab Emirates (UAE), Saudi Arabia, Mauritania and Kazakhstan where camel 
dairies exist and camel milk and milk products are produced (Wemery, et. ah, 2002). 
Camel’s milk is normally consumed in its raw state (boiling of the milk is not common as 
it is thought to remove its “goodness”). This, the high ambient temperature and the lack of 
refrigeration facilities in many arid areas give rise to considerable hygiene problems 
(Semereab & Molla, 2001).
Camel milk is considered a usefiil component of the diet for individuals that show allergic 
reactions to the protein fraction of cow’s, ewe’s or goat’s milk, as camel milk does not 
contain 13-lactoglobulin and the content of alpha-casein is much lower (Restani, et. 
al.,1999). A  trial on patients with multi-resistant tuberculosis showed that camel’s milk in 
comparison with cow’s milk had a positive effect on the general condition of the 
individuals (Mai, et. al.,2006). In addition, camel’s milk consumed every day appears to 
have a reducing effect on blood sugar level and increases the quality of life of people 
affected by type I diabetes mellitus allowing a reduction of the insulin dose (Agrawal, et. 
al.,2005). The controlling effect on hyperglycaemia is probably due to the content of 
insulin and the slower coagulum formation in the stomach which results in a faster stomach 
passage (Yagil, et. al., 1998; Agrawal, et. al., 2003). However, in the investigation of 
Breitling (2002) no blood sugar reducing effect was observed.
Although camel’s milk has salty taste and is more acidic, it is more nutritious than cow’s 
milk because it is low in fat and lactose, and higher in potassium, iron and vitamin C 
(Admin, 2010).
It has been reported that the milk of mammals is protected to different extents, against 
microbial contamination, by natural inhibitory systems. These include the 
lactoperoxidase/thiocyanate/hydrogen peroxide system (LPO), lactoferrins, lysozyme (LZ), 
immunoglobulins and free fatty acids (El Agamy, et. al., 1992; Kappeler, et. al. 1999). The 
animal species and the stage of lactation play an important role in the concentration and the 
activity of each of these antimicrobial substances. El Agamy, et. al., (1992) reported that 
the camel’s milk has a stronger inhibitory system than that of cow’s milk, especially with 
respect to the levels of lysozyme and lactoferrins which were reported to be two to three
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times higher than those of cow’s milk, respectively (Barbour, et. al. 1984; Kappeler, 1992). 
Camel’s milk lysozyme also seemed to have an activity spectrum more closely related to 
egg white LZ than that of bovine milk (El Agamy, et. al., 1992). In fact camel’s milk is 
used in some parts of the world as a cure for certain diseases (Wemery, 2003).
The activity of camel’s milk LPO was found to be dependent on the type of bacteria; being 
bacteriostatic against gram positive cultures, and highly bactericidal against gram negative 
strains (El Agamy, et. al., 1992).
1.11.2. Bacteria in camel’s milk
Milk is known to be a good medium for many bacteria to grow and growth depends largely 
on temperature and the presence of other bacteria (Heeschen, 1994). Since camel’s milk is 
usually consumed in its raw state, the occurrence of pathogenic bacteria may be of public 
health importance (Saad and Thabet, 1993; Younan, 2004). In general, bacteria in milk can 
be present through colonisation of the teat canal or an infected udder (clinical or 
subclinical mastitis), respectively, or as contaminants.
1.11.2.1 Contamination
Generally, the initial contamination of milk takes place in the moment of milking during 
the passage through the teat canal and by milking equipment or milking personnel. 
Contamination can also occur during transport and storage. Saprophytic micro-organisms 
are the main cause of spoilage in milk but mastitis pathogens are of public health concern 
as some of them are capable of producing toxins or causing infections in man (Heeschen, 
1994; Semereab and Molla, 2001).
1.11.2.2. Total bacterial count (TBC)
Researchers have found that the TBC of camel’s milk varies between 10  ^ and 10  ^ cfu/ml 
(Semereab and Molla, 2001; Wernery, et. al.,2002; Younan, 2004) and that these 
differences in TBC depend on many parameters such as the content of the camel’s milk 
itself, contamination of the camel’s udder, milking personnel and containers. The extent of
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contamination also varies according to the keeping and milking conditions of the camels. 
Under pastoral production conditions, the hygiene of raw camel’s milk strongly depends 
on environmental contamination rather than the initial bacterial contamination of the 
camel’s milk (Younan, 2004) and the raw milk was observed not to turn sour for 4 days, if 
the total bacterial count was low especially when it was kept in a clean container and 
refrigerated (Younan, 2004). In (Table 1) the average TBC’s from various studies are 
summarized.
Table (1) Average TBCs in camel's milk
Author(s) Country TBC (cfu/ml)
Sela, e/. o/., 2003 Israel 8 .0 x 1 0 ^ -5 .3 x 1 0 *
Wemery et. ai, 2002 UAE, bowl samples 94.1%< 1 .0 x 1 0 '
Younan, 2004 Kenya, udder samples 10--10^
Younan, 2004 Kenya, bucket samples 1 0 '-1 0 '
1.11.2.3. Conforms and Escherichia coli
Total conforms and Escherichia coli are recognized as indicators of the quality of food and 
the sanitation of the food processing environment (Feldsine, et. al., 2005). Both groups of 
organisms are known to be mastitis pathogens in cows (Schalm, et. al., 1971). In camel’s 
milk, coliforms have been reported by many authors especially from clinically healthy 
udders. (Table 2) shows the prevalence of coliforms and E. coli in camel’s milk and the 
carriage rate varies between 1.0 and 17.3% in samples taken from healthy camels (El- 
Jakee, 1998; Abdel Gadir, et. al., 2005) and from 1.4% up to 29.4% for coliforms in 
general (Saad & Thabet, 1993; Wernery, et. al., 2002).
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1.11.2.4. Escherichia coli
E. coli is considered to be a potentially pathogenic bacterium that causes severe intestinal 
and extraintestinal diseases in man (Kaper, et. al., 2004) as well as mastitis in the cow 
(Bradley and Green, 2001). Many microbial pathogens including Klebsiella pneumonia 
and E. coli, were isolated from clinical cases of camel mastitis (Kapur, et. al., 1982). A 
study by Abdel Gadir, et. al., (2005) showed that E. coli was mainly isolated from camels 
which exhibited signs of subclinical mastitis. The same study also reported one case of 
clinical mastitis caused by E. coli (Table 2).
Table (2) Number of samples positive for Coliforms and E. coli in camel’s milk
Author(s) Country „
Coliforms
&
g
E. co/f (%)
y
Samples(n)
Ï
Camel (n)
Healthy camels
Abdel Gadir et. al. 2005 Ethiopia 17.3 956 253
Barbour ei. al, 1985 Saudi Arabia 1,5 205 205
El-Jakee, 1998 Egypt 3.0 1.0 100 100
Guliye, 1996 Israel 86 86
Saad & Thabet 1993 Egypt 29.4 40 40
Semereab & Molla, 2001 Ethiopia X 8,3 130 130
Wernery et. al., 2002 UAE 1.4 1313 14
Healthy and mastitis camels
Sena et. a i,2000 India 9.3 150 X
Mastitis cases
El-Jakee, 1998 Egypt 11.0 6.0 100 100
Kapur et. ai, 1982 India X X 1 1
X= Present
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1.11.2.5. Coliforms
Coliforms are a heterogeneous group of Enterobacteriaceae (such as E. coli Klebsiella, 
Enterobacter, lactose positive biotypes of Citrobacter, Serratia and Hafnia). A high 
percentage of biotypes of these species originate from soil or water, some come from 
faecal contamination (Schmidt-Lorenz and Spillmann, 1988). Coliforms other than E. coli 
that are reported in camel milk include Klebsiella pneumonia (0.5 - 7.1 % of the milk 
samples) and Citrobacterfreundii (0.6 -  3.0 %). In most cases these bacteria are present in 
clinically healthy camel udders, but they have been isolated from cases of severe mastitis 
(Table 3)
Table (3) Coliform species in camel milk
Author(s) Country
Citrobacter
Freiinelni%)
Klebsiella 
pneumonia {%) Samples (n)
Camel
No clinical signs of mastitis
Abdel Gadir et. al. 2005 Etliiopia 0.9 956 253
Barbour of. al, 1985 Saudi .Mabia 0.5 205 205
El-Jakee, 1998 Eg\T)l 3.0 2.0 100 100
Semereab & Molla 2001 Etliiopia 0 6 7.1 130 130
Clinical signs of mastitis
Kapm et aJ., 1982 India 100 1 1
El-Jakee, 1998 Eg\-pf 1.0 100 100
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1.11.2.6. Salmonella
Salmonella spp. are facultatively aerobic, gram negative rod-shaped bacteria belonging to 
the family Enterobacteriaceae (WHO, 2005b). Salmonella spp. are of high importance in 
food safety being able to provoke severe intestinal infections in humans which can be fatal, 
especially in elderly people (Kleer, 2004). In countries all over the world, camels, like 
other animals, can be infected with Salmonella and some of the affected animals show 
clinical symptoms but others do not (Wemery, 2000). A study by Burgemeister (1974), 
confirmed the presence of a serological reaction to Salmonella (S. Typhimurium and S. 
Enteritidis) antigens in 5.8% of the examined camels. However, there haven’t been any 
cases reported of lactogenic transmissions from camels to humans (Younan, 2004). Faecal 
contamination is considered to be the most frequent reason for the presence of Samonella 
spp. in milk especially after heat treatment, as Salmonella are destroyed during 
pasteurisation (Kleer, 2004). Since 1996, no outbreaks of intestinal salmonellosis have 
been reported in animals in the UAE, while in Saudi Arabia and Kuwait intestinal 
Salmonella infections are occurring in livestock (OIE, 2004) and Salmonella are regularly 
isolated from healthy camels in the UAE (CVRL, 2006).
1.12. Lactoperoxidase
Lactoperoxidase (LP) is a member of the peroxidase family, a group of natural enzymes 
which are widespread in nature and exist in plants, animals and man (Kussendrager & 
Hooijdonk, 2000). The peroxidase enzymes in the mammals can be present and active in 
different types of secretions such as milk, saliva and tears and have no harmful effect on 
mammalian cells (Modi, et. al., 1991). A simple and convenient assay has been developed 
for the determination of levels of this enzyme in cow’s milk using 2,2’-azinobis(3- 
ethylbenzylthiazoline-6-sulphonic acid (ABTS) as a chromogenic substrate and following 
this reaction in a spectrophotometer at a wavelength of 412 nm (Kumar & Bhatia, 1999). 
Lactoperoxidase is the most abundant enzyme in milk after xanthine oxidase (XO) and its 
concentration in bovine milk is about 30 mg/L and it comprises approximately 1% of the 
total whey proteins (Fox and Kelly, 2006). The activity of the peroxidase in cow milk is 20 
times higher than that in human milk due to the LP concentration which is about 1.2 to 
19.4 units/ml (Watanabe, et. al., 2000), while in human milk it ranges from 0.06 to 0.97
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units/ml. The milk of guinea pigs as been found to contain the highest level of LP activity 
(22 units/ml) (Seifu, et. al., 2005).
Bovine lactoperoxidase consists of a single polypeptide chain, which contains 612 amino 
acid residues and has a molecular mass of about 78 kDa. It is a basic protein with a high 
isoelectric point of 9.6 (Kussendrager & Hooijdonk, 2000). LP has one haem group 
attached covalently by an ester bond to the active site of the polypeptide chain (Seifu, et. 
al., 2005). Another important aspect of the structure includes the addition of a calcium ion 
which aids the enzyme’s heat stability (Booth, et. al., 1989).
1.12.1. Lactoperoxidase system components
Biologically, LPO plays an important role as a natural host defence system and in vivo it 
protects the gut of the calf and the lactating mammary gland from many enteric micro­
organisms (Modi, et. al., 1991). LPO degrades many carcinogens and provides protection 
to the animal cells against peroxidative effects, and also protects mammalian cells against 
highly reactive and damaging oxygen-derived species (Seifu, et. al., 2005). Besides its 
antibacterial activity, (Kussendrager & Hooijdonk, 2000), LPO has been found to have 
antiviral and antifungal activity (Jacob, et. al., 2000). This ability of lactoperoxidase to 
contribute to the inhibition of microbial growth was first proposed by Hanssen in (1924) 
and was finally confirmed by Wright and Trammer (1958). LP enzyme alone has no 
antibacterial effect (Masud, et. al., 2010) and requires thiocyanate (SON ) and hydrogen 
peroxide (H2 O2 ). The three components form an active system known as lactoperoxidase 
system (LPO) which together produces substances that act as antimicrobial agents (Gurtler 
and Beuchat, 2007).
The thiocyanate (SCN ) is mainly a component of extracellular fluid that develops in the 
body due to dietary resources and smoking habits. It is present in different concentrations 
and is distributed in animal tissues and secretions. It also occurs in milk, salivary and 
thyroid glands; in body fluids such as plasma and lymph, and in organs like the kidney and 
stomach (Kussendrager & Hooijdonk, 2000). The levels in bovine milk vary depending on 
breed, species, udder health and type of feed (Kussendrager & Hooijdonk, 2000). Cows’ 
milk contains 1 - 1 0  mg per liter of SCN' and this amount is not sufficient to activate the
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LPO system (Davidson, 1997) since a higher concentration, between 14 and 15 ppm, has 
been suggested by Reiter & Hamulv (1984) to be required for activation purposes.
Hydrogen peroxide (H2 O2 ) is the third component of the lactoperoxidase system. It is 
found in cells, tissues and secretions as one of the main oxidants. H2 O2  can be harmful and 
penetrate through biological membranes and thus it should be used at the right 
concentrations and with care, to stop unnecessary damage (Conner, et. al., 2002). A 
concentration of 100 pM or less, in the presence of LP and SCN" to reduce its toxicity, has 
been shown to be tolerated by mammalian cells (Pruitt & Kamau, 1991). As a substrate for 
the LPO system, H2 O2  can be generated endogenously in several ways. Many bacteria such 
as lactobacilli, lactococci and streptococci are able to produce sufficient H2 O2  especially 
when these are incubated in air (Wolfson & Sumner, 1993). Polymorphonuclear leucocytes 
can also generate this compound when phagocytosing (de Wit & Van Hooydonk, 1996). 
Hydrogen peroxide can also be produced exogenously either by adding it directly to the 
medium (this might cause problems due to its reaction with proteins making it unstable 
(FAO & WHO, 2005), or by some enzymatic systems such as the oxidation of ascorbic 
acid by ascorbate oxidase, or the oxidation of glucose by glucose oxidase (GOD), and via 
xanthine oxidase (Kussendrager & Hooijdonk, 2000). Generating H2 O2  within a system 
has been found to be more effective than adding it directly (Klebanoff, et. al., 1966). When 
it is produced by the addition of GOD and glucose, it has a more prolonged inhibitory 
effect (McLay, et. a l, 2002).
1.12.2. Mechanisms of action
The inhibitory action comes from the ability of the lactoperoxidase enzyme to catalyse the 
oxidation of thiocyanate by hydrogen peroxide (Hogg & Jago, 1970), a process that yields 
short-lived intermediate oxidation products of SCN" that exhibit antimicrobial action (Aune 
& Thomas, 1978). The direct production of the hypothiocyanate anion (OSCN") is widely 
believed to be responsible for the antimicrobial activity as this reacts with free SH groups 
in bacterial enzymes at neutral pH. However, the system is so complex that it generates, 
indirectly, many other short-lived intermediates in small quantities which may also be 
bactericidal. These products are cyanogens thiocyanate (NC-SCN), cyanosulphuric acid 
(HO3SCN), and thiocyanogen (SCN)2 which is in equilibrium with hypothiocyanous acid 
(HOSCN at pK 5.3) (Thomas & Aune, 1978). The hypothiocyanate anion (OSCN") is
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thought to block the metabolism of the bacteria by damaging the inner membrane, causing 
leakage, stopping the uptake of nutrients, and consequently preventing the bacterial cells 
from multiplying (Fonteh, et. al., 2005).
The activity of LPO system has been shown to kill or inhibit the growth and metabolism of 
many bacterial species and strains. The activity and effectiveness varies depending on the 
reaction conditions, type of electron donor, temperature, test media, and pH. The degree of 
sensitivity to the LPO system varies between different groups of organisms, e.g. Gram 
negative bacteria such as species of Vibrio, Salmonella, Pseudomonas and Eschericha coli 
are generally more sensitive. With these organisms the effect of LPO system was 
inhibitory, but dependent on the media conditions, the effect could also be bactericidal 
(Bjorck, et. al., 1975; Banks & Board, 1985). Gram positive bacteria like Lactobacillus 
and Streptococcus have been found to be more resistant to the system and the effects of the 
system on this group of bacteria have been found to be mainly bacteriostatic (Slowey, et. 
al., 1968; Siragusa & Johnson, 1989). Studies reported that the difference in such 
behaviour could be due to the structure of the bacterial cell walls and their different barrier 
properties (de Wit & Van Hooydonk, 1996).
Bjorck and Claesson (1980) demonstrated that E. coli was killed by the antimicrobial 
agents produced from the reaction of LPO system when it was present in a semi-synthetic 
medium and that the system is active in the absence of other milk components. Strains of 
Salmonella Typhimurium have been shown to be sensitive to the LPO system and the 
bactericidal effect shown to be dependent on the permeability of the bacterial cell wall. 
Moreover, bacteria in the stationary phase of growth were found to be more resistant to the 
bactericidal effects than those from the exponential phase (Purdy, et. al., 1983). A study by 
Wolfson & Sumner (1993) again using Salmonella, demonstrated that the mode of 
inhibition depended on the number of cells present, and that with low densities up to 10  ^
cfu/ml the system was mostly bactericidal whilst at higher cell concentrations (10^-10^ 
cfu/ml) the system was mainly bacteriostatic.
The activity of the LPO system against the Gram positive food-borne pathogen Listeria 
monocytogenes Scott A in laboratory media was demonstrated to be bacteriostatic as 
assessed from the increased lag-phase of 12 to 36 h observed in the presence of the system 
versus a 9 h lag-phase seen in the control sample (Siragusa & Johnson, 1989). In addition, 
Bibi and Bachmann (1990) reported that the growth of strains of L. monocytogenes and L.
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innocua was inhibited by the LPO system in skimmed milk at 30°C. Some studies, such as 
that by Gaya, et. rz/. (1991) have demonstrated that the LPO system is bactericidal towards 
cells of L. monocytogenes at 4°C and 8°C, but this activity was dependent on temperature, 
incubation period and bacterial strain used.
LPO has also been shown to have bactericidal activity against another major food-borne 
pathogen, namely C. jejuni in milk, with the effect being more pronounced at higher 
temperature and pH 6.6 (Beumer, et. al., 1985; Borch, et. al., 1989).
The LPO system has also been shown to be active in milk from other animals. For 
example, a study conducted by Zapico, et. al., (1995) showed that E. coli was inhibited in 
goat’s milk which had been held at 8°C for 5 days. Similarly, the LPO system in 
indigenous Saanen and South African goat’s milk was also shown to be bacteriostatic 
against E. coli when kept at 30°C (Seifu, et. al., 2004).
Many other bacteria includes Aeromonas hydrophila, Escherichia coli, Klebsiella 
pneumoniae. Salmonella enteritidis. Shigella dysentriae. Staphylococcus citreus and Vibrio 
choierai showed sensitivity to the LPO system extracted from goat’s milk with a zone of 
inhibition for all of them more than 15 mm radius (Jacob, et. al., 2000). However when 
goat’s milk lactoperoxidase alone was used, two organisms showed some resistance, viz., 
Citrobacter freundi and Pseudomonas aeruginosa, but these were found to be more 
sensitive when the whole system was used gLP-H2 0 2  and thiocyanate, forming a zone of 
inhibition greater than 19-20 mm (Jacob, et. al., 2000).
A study by Kamau, (2010) showed the effect of the LPO system after activating it by 
adding 8.5 ppm H2 O2  on the viable bacterial count in raw camel’s milk during storage at 
10°C, 20°C and 30°C was variable. At 10°C there was a small decrease in numbers (< 1 
log cfu/ml) over 72 hrs of incubation period. At 20°C a similar reduction took place more 
quickly but after 10 hrs the organism had started to increase in numbers again. At 30°C the 
only apparent effect was an extended lag phase of about 10 hrs. This finding shows that the 
effect of LPO system on total bacterial counts is temperature dependent (Kamau, et. al., 
2010).
The growth of Listeria monocytogenes Scott A was also found to be inhibited by the LPO 
system in a bacteriostatic manner (Siragusa and Johnson, 1989). This bacteriostatic effect 
is in agreement with previous studies on the effect of the LPO system on other gram-
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positive bacteria (Reiter and Hamulv, 1984). Moreover, the LPO system added to the milk 
was active against inoculated Salmonella Enteritidis at a number of approximately 10"^  and 
10^  cfu/ml and the growth of the organism was inhibited in UHT whole milk and skim 
milk for almost 4 h, after which no inhibitory effects were observed. Although the effect of 
added LPO system was in both UHT and skim milk, it was more effective in skim than in 
whole milk, this suggest that milk fat might inhibit its antimicrobial action (Touch, et. ah,
2004).
The effect of LPO system on the milk spoilage organism Pseudomonas fluorescens was 
also observed in a study by Bjorck, (1975) which showed that when raw milk contained 
0.085 mM SCN’ and 0.3% glucose, the organism failed to multiply in the presence of the 
enzyme for up to 10 h. After that time it multiplied at the same rate as the control. 
However, when a higher concentration of thiocyanate (0.17 mM) was used, the number of 
organisms declined rapidly in the first 4 h of incubation, remained nearly static for the next 
6 h, but increased from 10 h onwards at approximately the same rate as the control (Bjorck, 
et. ah, 1975).
In another study, the antimicrobial effect of the LPO system was shown to extend the shelf 
life of milk using three bacteria of importance to milk spoilage, Staphylococcus aureus. 
Pseudomonas aeruginosa, and Bacillus cereus (Fweja, et. ah, 2008). Although the system 
exerted complete inhibition of P. aeruginosa over 10 h incubation, the bacteria regained 
viability after further 5 h. With S. aureus the lag phase was extended by 5 h before the 
bacteria recovered and resumed logarithmic growth, while with B. cereus the lag phase 
was prolonged by 10 h, followed by the normal bacterial growth rate (Fweja, et. ah, 2008). 
The activity of LPO system against some other gram-negative bacteria such as E. coli 
0157:H7, Salmonella enterica, Campylobacter jejuni, Aeromonas hydrophila and Yersinia 
enterocolitica was investigated. No effect was observed on E. coli 0157:H7 when 
resuspended enzyme from bovine milk - Sigma, St Louis, MO, USA - in distilled- 
deionized water to 5mg/ml was added to the milk at refrigerator temperature 4°C. However 
a clear inhibition was seen with the other four pathogens. The viable counts obtained for S. 
enterica, A. hydrophila and Y. enterocolitica were lower in milk with LPO system than in 
control milk after 12 days at 4°C, although Y. enterocolitica restarted growth at the end of 
incubation period on the same constant temperature. C. jejuni stayed below the detection
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limit (1 cfu/mi) in milk with LPO system from day 5 of refrigeration at 4°C (Arques, et. 
al, 2008).
Eamshaw et. aï., (1989) found that the activation of lactoperoxidase reduced the numbers 
of Pseudomonas, E. coli and S. Typhimurium in cottage cheese. Pseudomonas was 
undetectable throughout the 21 day storage period whereas the control count reached 10  ^
cfu/g within 14 days of storage. S. Typhimurium was stable in the control throughout 
storage but was undetectable in the LPO activated cottage cheese. E. coli levels in the 
control cottage cheese declined from 10  ^to undetectable levels during storage whereas in 
the LPO product the organism was not detected throughout storage.
LPO appeared to have a less pronounced effect on Enterohacter sakazakii (Gurtler and 
Beuchat, 2007). Milk powder formula for infants containing an initial population 0.04 
cfu/ml and treated with 10, 20 and 30 pg/ml LPO was positive for the pathogen by 
enrichment. At 21°C and 30°C some samples gave positive results especially when treated 
with LPO at 10 or 20 pg/ml. However, none of the samples of formula treated with 10, 20, 
or 30 pg/ml LPO and stored at 37°C was positive for E. sakazakii by enrichment at any 
sampling time during storage for 24 hrs. The inhibitory or lethal activity o f LPO against E. 
sakazakii is clearly greater at 37°C than at 21 or30°C
Synergies with other antimicrobials have been reported. Boussouel el. a l, (1999) found 
that activation of the LPO system and addition of nisin had a synergistic effect on L. 
monocytogenes ATTCC 15313 in skim milk. Kennedy, et. a l, (2000) found that the 
combination of the LPO system and monolaurin inhibited growth of E. coli 0157, L. 
monocytogenes and S. aureus in ground meat.
Study conducted by Fweja, et. a l, 2008 showed that replacing thiocyanate (SON') with (T) 
in the LPO system exhibited great antimicrobial activity against some food pathogens such 
as Pseudomonas aeruginosa. Staphylococcus aureus and Bacillus cereus. The effect of 
LP+T+H202 was bactericidal against P. aeruginosa and the bacterial counts reduced below 
the detection limit just after treatment, and no counts were detected up to the end of the 
experiment. Similar observation was seen when the system was used against Staph, aureus, 
and the effect was bactericidal. However, the bacterial counts were reduced to below the 
detection limit after 5 h of incubation. The LP+T+H202 system resulted in similar
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bactericidal action against B. cereus as with other strains, and the bacterial counts were 
below the detection limit within 10 h of incubation (Fweja, et.al., 2008).
1.12.3. Effect on fungi and viruses
Many previous studies have shown that the LPO system is not only effective against 
bacteria, but it also kills viruses and fungi such as Candida tropicaJis especially when an 
iodide ion (F) is used as electron donor instead of SON' (Hamon & Klebanoff, 1973). The 
fungicidal activity has also been observed for species of Geotrichum, Rhodoturula, 
Saccharomyces and Aspergillus (Lehrer, 1969). This activity though appears to be 
dependent on the nature of the medium and the components used in the system. Moulds, 
for example, exhibited total inactivation in salt solution within 2 h of incubation, when a 
concentration of (5 U/ml) and (1 U/ml) of LP and glucose oxidase were used, respectively 
(Naidu, 2000).
The killing effect of LPO system has also been demonstrated for viruses. Belding, et. al., 
(1970) demonstrated antiviral activity on poliovirus and the vaccine virus (the most 
resistance to heat, disinfection and drying) when SCN' was replaced by (F and Br") as 
electron donors. Studies have also shown that the human immunodeficiency virus type-1 
(HIV-1) is inhibited by the OSCN produced from LPO system (Pourtois, et. al., 1990).
1.13. Xanthine Oxidase
Xanthine oxidoreductase (XOR) is a complex molybdoflavoenzyme which uses xanthine, 
hypoxanthine and reduced nicotinamide adenine nucleotide as electron donors. It catalyses 
the hydroxylation of hypoxanthine to xanthine and then to uric acid. The enzyme is 
synthesized as xanthine dehydrogenase (XD) but by proteolysis or oxidation of its 
sulfhydryl residues, it is readily converted into xanthine oxidase (XO) (Silanikove, et. al.,
2005). This enzyme is present in many organs of the body and also in mammalian milks 
including cow’s milk from which it was purified 60 years ago. It is highly expressed in 
mammary epithelial cells, and especially in the liver and intestine. In mammary cells it is 
produced during lactation, and it is the predominant protein in the membrane of milk-fat
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globules and therefore, the milk consider being a rich source of the enzyme (Stevens, et. 
a l, 2000).
Xanthine oxidase is an enzyme capable of oxidising a wide range of purines, pteridines and 
aldehydes with concomitant reduction of O2  and H2 O2  (Whitaker, et. al, 2003). Under 
certain conditions, it can generate weakly microbicidal superoxide and hydrogen peroxide, 
which may give antimicrobial protection to the neonatal stomach. However, superoxide 
and hydrogen peroxide production are greatest at a pH above 7 and require the presence of 
oxygen and the pH of the neonatal stomach generally ranges between pH 4 and pH 6 with 
an oxygen concentration at or below 5%. (Brown, et. al„ 1988).
The results of Weihrauch (Weihrauch, 1988) show that in the presence of purines, XO 
produce H2 O2  for the lactoperoxidase system in milk, which make it a bacteriostatic agent 
in milk (Whitaker, et. al, 2003).
Peroxynitrite is a potent oxidising, hydroxylating and nitrating agent (Pryor and Squadrito,
1995). It can mediate the oxidation of many biological molecules such as sulphydryl 
compounds, proteins, lipids and DNA (Rubbo, et. al., 1994; Quijano, et. a l, 1997). 
Peroxynitrite can result from the reaction of nitric oxide (NO) with superoxide anion (Huie 
and Padmaja, 1993). The latter can result from the activities of many enzymes as well as 
mitochondrial oxidases and xanthine oxidoreductase (XOR) (Harrison, 1997; Hancock, 
1997). Nitric oxide normally occurs from NO synthase-catalysed oxidation of arginine in 
the presence of NADPH and molecular oxygen (Knowles and Moncada, 1994). However, 
a study by Godber, (2000) showed that incubation of XOR with inorganic nitrite, oxygen 
and pterin exhibited rates of peroxynitrite production which were proportional to the 
concentration of enzyme and could be fully inhibited by oxypurinol (Massey, et. a l, 1970). 
The author also proposed that peroxynitrite has a bactericidal role in milk and in the 
digestive tract (Godber, et. a l, 2000).
The XO generated NO and peroxynitrite are believed to have an antimicrobial role in the 
neonatal gut for several reasons, both spatial and catalytic. The location of XO on the outer 
surface of the milk fat globule membrane, that is itself of epithelial cell origin, allows the 
targeting of pathogenic bacteria which normally bind to the epithelial membranes o f the 
digestive tract and will bind to similar antigens on the milk fat globule membrane (Keenan 
and Patton, 1995). This phenomenon will divert the pathogenic bacteria from their primary 
target and also bring them into intimate contact with OX. Consequently, the local
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concentration of NO and peroxynitrite produced in the environs of the bacteria could 
potentially be very high and could account for the antibacterial effects seen (Hancock, et. 
al, 2002).
Aims of this study
Given that cow’s milk can be a vehicle for Campylobacter infection, the aim of this study 
was to study the interaction of these food-home pathogens with this commodity. In 
addition, because the study was funded by the Dubai government the other aim was to 
study camel’s milk as a vehicle for Campylobacter given that this milk, and not cow’s 
milk, is the most popular milk in this country. Specific aims were as follows:
• Characterise the affect of temperature on the survival of Campylobacters in milk.
• Characterise any antl-Campylobacter activity that was found to be present in milk
• Determine the source of this activity (e.g. LPO or XO).
• Determine the sensitivity of other food-bome pathogens {E.coli, Salmonella and
Listeria) to this activity in comparison to Campylobacter.
• Investigate the carriage of Campylobacter in camel’s milk in the context of its LP
activity.
• Determine whether H. pylori is susceptible to the bactericidal activity present in 
pasteurized milk.
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CHAPTER 2 
MATERIALS AND METHODS
2.1. Materials and Methods
Appendix A, B, C and D describes all media, buffers and solutions used in this study.
2.1.1. Cultures and strains
2.1.1.1. Bacterial strains
All strains of Campylobacter species and other organisms used in this study are described 
in (Table 4). The genome strain, NCTC 11168, of C. jejuni was used in all experiments, 
unless otherwise stated.
2.I.I.2. Preparation of Bacterial Cultures
A total of twelve strains of C. jejuni and thirteen strains of C. coli obtained from the 
National Collection of Type Cultures (Colindale, UK) and the Veterinary Laboratories 
Agency (Weybridge, UK) were used in this study. Other organisms such as {Salmonella 
Enteritidis, Listeria monocytogenes, and E. coli 0157:H7) were obtained from the 
University of Surrey culture collection. Frozen stocks of all organisms were stored at - 
80°C in mini micro-bank tubes (Pro-Lab Diagnostics, Richmond Hill, Canada) until use.
For experiments with Campylobacter strains, a loop full of the frozen stock solution was 
inoculated into 30 ml of Mueller Hinton Broth (MHB) (Oxoid), and the cultures were kept 
under microaerophilic conditions (5% O2 , 10% CO2 , and 85% N 2 ) generated by the 
CampyGen kit (Oxoid) at 37°C. The character of the bacteria was observed under the 
microscope and all strains showed high motility and spiral rod morphology after gram 
staining. The strains were streaked onto selective modified cefoperozone charcoal 
deoxycholate agar (mCCDA; Oxoid), Skirrow’s agar (Oxoid) with 5% laked and 
defibrinated horse blood (Oxoid), and the general medium Mueller Hinton Agar (MHA; 
Oxoid). All plates were incubated under microaerophilic conditions at 37°C for 48 hrs. For 
Salmonella, Listeria monocytogenes and E. coli 0157:H7, cultures were grown up to 10^  
cfu/ml in 15 ml of Nutrient Broth by incubating cells aerobically at 37°C for 24 hrs. The 
viability was assessed by streaking the strains onto selective XLD agar. Listeria selective 
agar and MacConkey agar respectively. All plates were incubated aerobically at 37°C for 
24 hrs.
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When necessary for selection, antibiotics were used in the media at the following 
concentrations; ampicillin 100 pg ml'^ and kanamycin 50 pg m l'\
A strain of Helicobacter pylori (NCTC 11637) used in the latter part of this study was 
obtained from the National Collection of Type Cultures (Colindale, UK) and was 
maintained at -80°C in mini micro-bank vials as described above. H. pylori was usually 
grown on Colombia agar supplemented with 5% horse blood and brain heart infusion agar 
supplemented with horse serum (HS). Routinely, cultures were incubated at 37°C under 
micro-aerobic condition for 3 to 7 days.
2.I.I.3. Bacterial Growth Curves and Plate Counting
Standard growth curve determinations were conducted as follows. One ml of an overnight 
culture of Campylobacter jejuni was inoculated into 50 ml of MHB. The culture was 
incubated at 37°C under microaerobic conditions with shaking (150 RPM) and readings of 
optical density (ODeoo) were taken regularly over a period of three to five days. To 
enumerate the cells of Campylobacter present in the culture, a decimal dilution series was 
prepared using Maximum Recovery Diluent MRD (Oxoid, Basingstoke, UK). These 
dilutions were then plated onto MHA using two enumeration methods which were used at 
different times. For the Miles & Misra technique five drops of 20 pi of suspension were 
deposited in each dilution on plates that had been divided so that several such drops could 
be accommodated. In the spread plate method 0.1 ml of the dilutions were spread over a 
whole plate using a sterile spreader. All plates were incubated at 37°C under microaerobic 
conditions for 48 h prior to counting.
2.1.2. Milk Samples
The Ultra High Temperature (UHT) skimmed milk, pasteurized skimmed milk and 
Cravendale filtered skimmed milk used in the study were all obtained from a local 
supermarket (Tesco, UK).
Samples of raw camel’s milk were collected by the author and well trained food control 
inspectors. Samples were obtained from different herds and collected in sterile plastic 
containers normally used for packaging pasteurized milk, and kept on ice during transport
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to the food microbiology laboratory at the Dubai Central Laboratory (Dubai). All samples 
were analyzed upon arrival.
The pasteurized camel’s milk used in the study were obtained from Emirates industries and 
a local supermarket (Dubai, UAE; Union Co-operative, Dubai), respectively.
2.1.21. Assessing the Survival of Campylobacter in milk
To establish survival in the different types of milk, C. jejuni was cultured from frozen by 
using a loop to inoculate a Mueller-Hinton Agar (MHA) plate which was then incubated at 
37°C under microaerobic conditions for 48 h. A loop full of this culture was inoculated in 
30 ml of Mueller-Hinton Broth (MHB), which was then incubated under microaerophilic 
conditions for 24 h. This step was carried out to allow the organism to adapt to the liquid 
environment. The optical density of the liquid culture was then adjusted to an ODeoonm of 
0.6, and the characteristic morphology and motility of the bacteria confirmed under a 
microscope. An aliquot (1 ml) of the adjusted bacterial cultures was transferred into 99 ml 
of the various samples held in 200-ml screw-capped tissue culture flasks with ventilation 
(Sterile Nunclon Surface) and these were incubated aerobically with shaking (150 RPM) at 
various temperatures or with various additions as described later. Samples (100 pi) were 
taken at regular intervals and decimally diluted using MRD. An aliquot (0.1 ml) of each 
dilution (5 x 20 pi drops) was placed onto various selective and non-selective media using 
the Miles & Misra technique. Plates were incubated at 37°C under microaerophilic 
condition for 48 h and representative Campylobacter colonies counted. All experiments 
were performed at least in duplicate.
These studies were initially carried out with the genome strain NCTC 11168 but in order to 
assess the general survival of Campylobacters in milk, the survival of other strains of C. 
jejuni and C. coli was also studied (Table 4).
When necessary the pH of the milk during the survival experiments was assessed by 
removing a sample and measuring this value with an Orion model 410A pH meter that had 
been calibrated immediately before use.
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2.I.2.2. Assessing the survival of non-microaerophilic food-borne pathogens in 
milk
The survival of other food-bome pathogens in milk was also assessed to allow comparison 
with Campylobacter. In this context, the survival of. Salmonella Enteritidis, Listeria 
monocytogenes and a non-toxigenic strain of E. coli 0157: H7 was assessed. The 
experiments were carried out as above except that the cultures used to inoculate the milk 
were overnight cultures containing 10  ^ cfu/ml and the selective media used were XLD 
agar. Listeria Selective Agar, and MacConkey agar, respectively.
2.1.2 3. Sterlization of milk by filtration.
In order to remove the existing microflora from milk and to examine its impact on 
Campylobacter survival, 10 ml of pasteurized milk was filtered by passing it through 0.22 
pm and 0.45 pm filters (Millipore).
2.1.2.4. The survival of C. jejuni in milk after the removal of the natural the 
micro-flora by filtration
This experiment was carried out to determine whether the natural micro-flora present in 
pasteurized milk played a role in the killing of C. jejuni. Ten ml of pasteurized milk was 
sterilized as described above and placed in a sterile 50 ml tube (Sterilin). An aliquot (100 
pi) of C. jejuni, prepared as above was introduced and the sample was incubated 
aerobically at 25°C, and samples for viable cell counts taken at regular intervals.
2.1.3. Detection of Campylobacter jejuni and other microbial indices of 
quality such as TVC, Coliforms, E, coli and Salmonella in camel’s milk in 
UAE (Dubai).
In the period, September 2008-February 2009 a total of 280 samples were analysed for the 
presence of C. jejuni and other microbes such as TVC, coliforms, E. coli and Salmonella in 
25 ml milk samples using FDA qualitative and quantitative methods (US-FDA, BAM, 
2007). From the total 280 samples, 171 samples were analyzed for C. jejuni, 109 samples 
for TVC and 66 samples for coliforms, E. coli and Salmonella.
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2.1.31. Isolation of TVCs
After cleaning and sanitizing the working area, 1 ml of raw camel milk was transferred to 
labelled petri dishes, and 10 ml of PC A agar (Appendix 1-A) medium was poured into 
plates. All plates were swirled to mix and were left to solidify. Plates were inverted after 
solidification and incubated for 24-48 hrs at 35°C. After incubation the plates containing 
fewer than 250 colonies to be counted and recorded as cfu/ml.
2.1.3.2. Isolations and Enumeration of Coliforms and E.coli
2.I.3.2.I. Enumeration of Coliform Bacteria
1 ml of raw camel milk samples was transferred to labelled petri dishes, and 10 ml of 
VRBA (Appendix 1-A) medium tempered 48°C was poured into plates. All plates were 
swirled to mix and were left to solidify. To prevent surface growth and spreading of 
colonies, 5 ml VRBA medium was overlaid and left to solidify again. All plates were 
inverted after solidification and incubated for 18-24 hrs at 35°C. Plates were examined on 
a colony counter by counting all purple-red colonies, 0.5 mm or larger, which are 
surrounded by a zone of precipitated bile acids.
Suspected colonies were transferred to a tube of BGLB (Appendix 1-A) broth for 
confirmation and then incubated at 35°C for 24 and 48 hrs. The production of gas in BGLB 
tube confirmed as coliform organism positive.
2.I.3.2.2. Enumeration of E.coli
10 ml of raw milk samples were pipetted into 10 ml of Mac Conkey broth (Appendix 1-A) 
tubes. All tubes were incubated at 35°C for 48 hrs. Positive tubes will produce acid/gas, 
which then a loopful of broth from each of the acid/gas-positive cultures were inoculated 
into separate tubes of BGLB. All the later tubes incubated at 44.5°C in water bath. The 
BGBB tubes were read for gas production after 24 h and 48 hrs.
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2.I.3.2.3. Identification tests for coliforms/JE.co/f organisms
A loopful of each gas-positive BGLB tube either from Coliform or E. coli were streaked on 
separate plates of EMB and TBX agar. All plates were inverted and incubated for 18-24 
hrs at 35°C. The representative colonies (suspected) nucleated, with or without metallic 
shine from an EMB (Appendix 1-A) plates and green colonies from TBX (Appendix 1-A) 
plates were picked out using an inoculating needle and streaked on Nutrient agar 
(Appendix 1-A) slant and to the IMViC media (Appendix 1-A). All tubes were incubated 
at 35°C for 18-24 hrs. Gram stain on a smear from the Nutrient agar culture was performed 
and the results of the IMViC tests were read after adding the necessary test reagents 
(Appendix 1-C). The presence of coliform organisms was identified by occurrence or gram 
negative, non-spore forming rods bacteria. While the results of IMViC test express the 
presence of E. coli bacteria.
2.1.3.3 Samonella
The isolation of Salmonella required four basic steps: Pre-enrichment, Selective 
enrichment. Selective plating and Identification of the Isolation.
2.1.3.31. Pre-enrichment
225 ml of pre-enrichment broth buffer peptone water (Oxoid, Basingstoke) (Appendix 1- 
A) was aseptically poured into 25 ml raw camel milk samples contained in stomacher bags. 
The top of bags were wrapped with a twist-tie and gently shaken horizontally for 30 sec. 
using a bench top rotary shaker. All bags were sealed and incubated at 35°C for 18-24 hrs.
2.I.3.3.2. Selective Enrichment
The pre-enrichment cultures were gently mixed and 1 ml from each bag of the broth 
cultures were pipetted and transferred to 10 ml of Selenite cysteine Broth and 1 ml to 10 
ml of Tetrathionate Broth (Appendix 1-A), and then another three drops of 0.1 ml was 
inoculated in separate spots on the surface of the MSRV (Appendix 1-A) medium plates. 
Both types of tubes were incubated for 24 hrs at 35°C, while MSRV plates were incubated 
in an upright position at 42°C for up to 24 h.
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2.I.3.3.3. Selective Plating and Isolation
Each bag was gently mixed and 3mm loopflils of grown culture were streaked 
simultaneously onto the surface of XLD agar and Hektoen enteric agar plates (Appendix 1- 
A). The MSRV plates were examined for motile bacteria, which should show a halo 
originating from bacterial movement, the positive plates then subcultured from the outside 
edge of the halo of the growth to selective agars. All plates were incubated at 35°C for 24 
hrs. Incubated plates were examined for colonial morphology typical of Salmonella. On 
XLD agar, typical colonies appeared as pink colonies with or without black centres. Many 
Salmonella may have large black centres or may appear as almost completely glossy black 
colonies. On Hektoen enteric agar, blue green to blue colonies with or without black 
centers will appear. The identity of all suspected colonies was confirmed by biochemical 
screening tests by inoculating the TSI agar, LIA agar and Urea agar (Appendix 1-A) using 
sterile inoculated needle.
2.1.3.4. Isolation of Campylobacter.
2.1.3.4.x. Enrichment
100 ml of Enrichment broth (Oxoid, Basingstoke) with EBP (Ferrous sulphate, sodium 
metabisulfite and sodium pyruvate), lysed horse blood and antibiotic solution (sodium 
cefoperazone. Trimethoprim lactate. Vancomycin and Cycloheximide) were aseptically 
poured into 25 ml raw milk samples contained in stomacher bags. The tops of bags were 
wrapped with a twist-tie and gently shaken horizontally for 5 min using a bench top rotary 
shaker.
All bags were placed in a jar system (Gaspak) and incubated at 35°C for 4 hrs under 
microaerophilic conditions in an incubator. After the 4 hrs incubation, another 15 mg/1 of 
cefoperazone was added to the bags using a 1-ml syringe to inject the antibiotic through 
the opening at the top of bags. After that the Gaspak jars were transferred to a 42°C 
incubator and the enrichment broths incubated statically for 23 hrs under a microaerophilic 
atmosphere.
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2.I.3.4.2. Selective Isolation
Each bag was gently mixed and a 3mm loop-full of grown culture was streaked 
simultaneously onto the surface of a Campylobacter blood-free agar (CCDA) plate and 
incubated at 35°C for 24-48 hrs under microaerophilic conditions. Incubated plates were 
examined for colonial morphology typical of Campylobacter. On CCD A, typical colonies 
appeared as small, grayish colonies and round or irregular in shape. Non- typical colonies 
were slightly transparent to slightly off white colored. The identity of all suspected 
colonies was confirmed by oxidase test, gram stain and motility observation using a 
microscope.
2.1.4. The survival of Campylobacter in pasteurized camel’s milk was 
assessed as described in (Section 2.1.2.1) of Materials and Methods.
2.1.5. Preparation of the in vitro lactoperoxidase system (LPO)
The Lactoperoxidase system (LPO) consists of three compounds the lactoperoxidase 
enzyme ‘LP’, thiocyanate ions (SCN') as sodium thiocyanate (NaSCN) and sodium 
percarbonate (as an H2 O2  source). These reagents were purchased from (Sigma, Fisher 
Scientific and ACROS Organics) respectively, and were prepared as outlined in the 
FAG/WHO guidelines (FAG & WHO, 2005). Concentrated solutions were made and 
sterilized by passing through 0.22 pm filters and used immediately after preparation and 
added to milk and buffers so that the final concentration of LPG system reagents in the 
survival studies was 30mg/l lactoperoxidase 14mg/l, NaSCN and 30mg/l, percarbonate 
respectively. The same solutions and concentrations of reagents were used to restore the 
LPG system to UHT skimmed milk.
2.1.6. Assay of thiocyanate
Thiocyanate is one of the essential compounds to activate the lactoperoxidase system and 
can limit its activity. Consequently, this study sought to measure its concentration in 
different types of commercial milks using CAC/GL 13-1991 method (CAC/GL, 1991) as 
outlined below.
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A sample of milk (4.0 ml) was mixed with 2.0 ml of 20% trichloroacetic acid (TCA) 
solution. After blending the mixture well; it was allowed to stand for 30 minutes then 
filtered using a Whatman No. 40 filter paper. An aliquot (1.5 ml) of the clear filtrate was 
mixed with 1.5 ml of (16.0 g Fe(N03)3.9H20 dissolved in 50 ml 2 M HNO3 and made up 
100 ml) ferric nitrate solution. After mixing, the sample was placed in a plastic cuvette and 
the absorbance at 460 nm measured. To prepare a blank control solution of 1.5 ml of RO 
water was mixed with an equal volume of ferric nitrate. A standard curve for thiocyanate 
was prepared using potassium thiocyanate at known and different concentrations (5, 10, 
15, 20 and 30 pg/ml), and the concentration of thiocyanate in the milk samples determined 
using the standard curve
2.1.7. Assay of lactoperoxidase
The level of lactoperoxidase in milk samples was measured using the method of Kumar 
and Bhatia (1999).
A volume (0.1 ml) of milk held at 4°C was mixed in cuvette with 2 ml of ABTS in 
phosphate buffer (0.1 M, pH6.7). To initiate the reaction, 1 ml of 0.3 mM hydrogen 
peroxide was added and the contents of the cuvette mixed. The reaction was monitored for 
1 min at room temperature and the absorbance was measured at 412 nm using a 
spectrophotometer and these values expressed as a function of time at 10s intervals over a 
period of 2 min. A reagent blank was prepared by combining the ABTS and enzyme 
solutions as described above but with no hydrogen peroxide added. Each sample was 
assayed 5 times and the result expressed as the conversion of ABTS in pm/min.
2.1.8. The effect of the catalase enzyme and removal o f H 2 O2 on the 
survival of C  jejuni in milk
In order to determine the contribution of the LPO system in to the death of Campylobacter 
in milk, initiation of the reaction was prevented by the addition of catalase and survival 
comparisons made. A stock solution of the enzyme was made by dissolving catalase from 
bovine liver (Sigma), in phosphate buffer saline (PBS) to a concentration of 50000 
units/ml. This was sterilized by passing it through a 0.45 pM filters (Millipore). This was 
added to the milk in the survival experiments outlined above to give final concentrations of
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100 units/100 ml, 500 units/100 ml and 1000 units / 100 ml. Samples with or without the 
enzyme were incubated at 25°C and sampled as described above.
2.1.9. The inactivation of the natural lactoperoxidase in milk.
To determine the contribution of the LPO system to the antimicrobial activity in milk, 
lactoperoxidase was inactivated using two methods, a non-specific heat treatment (Beumer, 
et. ah, 1985) and a specific chemical inhibitor of the enzyme (Borch, et. al. 1989).
For the heat treatment, a pasteurized skimmed milk sample was transferred into a sterile 
container and heated for 20 min at 100°C. The inhibitor sodium meta-bisulphite (Na2S20s) 
was used to specifically inhibit LP activity. A stock solution of 100 mM of Na2S20s was 
made by dissolving it in distilled water and sterilizing it by passing it through a 0.45 pM 
filter (Millipore). An aliquot (1 ml) of the prepared stock solution was transferred to 99 ml 
of milk containing Campylobacter to generate a final concentration of 1 mM. Survival 
experiments were carried out in the presence or absence of this compound and viability 
assessed as described above.
2.1.10. The use of oxypurinol to inhibit xanthine oxidase in milk.
Xanthine oxidase (XO) is another enzyme found naturally in milk that has antimicrobial 
activity (Bjorck, and Claesson, 1979). Oxypurinol is a powerful inhibitor of XO and was 
used to determine whether this enzyme contributed to the killing of Campylobacter. Stock 
solutions of 2.5 mM and 5 mM oxypurinol were prepared by dissolving the compound in 5 
ml of 95% ethanol, and then adding distilled water to make the volume up to 50 ml. 
Aliquots (1 ml) of the prepared stock solutions were transferred to 99 ml milk to generate 
final concentrations of 25pM and 50 pM. Survival in the presence or absence of these 
compounds was then assessed as described previously.
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2.1.11. The survival of C. jejuni on chicken skin after addition of 
pasteurized milk containing natural lactoperoxidase
Chicken skins were obtained from local supermarket (Tesco, UK), washed using running 
water and then, 10 g of chicken skin was cut and placed aseptically on 12 sterile petri dishes. 1 
ml of 24 h C. jejuni culture was transferred to the chicken skin in each plate. Four plates were 
inoculated with 1 ml of pasteurized milk, as natural lactoperoxidase source. The other four 
were inoculated with 1 ml distilled water and the remaining four were used as control samples 
without addition of anything. All plates were incubated aerobically at 25 °C; serial dilutions of 
samples from each category were taken at suitable interval time for viable cell counts, which 
were obtained using Miles & Misra technique on mCCDA plates.
Table (4) Bacterial strains used in the study
Bacterial strain Source and References
Campylobacter jejuni (Cj)
11168 *NCTC
11828 NCTC
Cj-ltoCj-10 D. Newell VLA (agency-Weybridge)
Campylobacter coli (Cc)
11350 NCTC
12110 NCTC
11437 NCTC
Cc-1 to Cc-10 D. Newell VLA (agency-Weybridge)
Salmonella enterica serovar Enteritidis University of Surrey (laboratory stock)
F. co//0157:H7 University of Surrey (laboratoiy stock)
Listeria monocytogenes University of Surrey (laboratory stock)
Helicobacter pylori \\316 NCTC
NCTC: National Collection of Type Cultures, Colindale Avenue, London
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2.2. DNA methodology
This section describes the technique used to construct SkatA mutant in C. jejuni 11168
2.2.1. Extraction of genomic DNA from C. jejuni (wild type)
Strain NCTC 11168 of C  jejuni was used for the genomic DNA extraction. The organism 
was grown on MHA in microaerophilic conditions at 37°C for 48 h. A loop full o f 
harvested cells was inoculated into 700 ml of distilled water in a 1.5 ml Eppendorf tube. 
The tube was vortexed and then centrifuged for 5 min at 15.7 g. The supernatant was 
discarded. The pellet was re-suspended in 100 ml TE buffer (Appendix B) by vigorous 
pipetting, and the cells lysed by the addition of 500 ml GES lysis buffer (Appendix C). The 
mixture was incubated at room temperature for 10 min, mixed by gentle inversion and then 
cooled on ice for 5 minutes. An aliquot (250 ml) of ice cold ammonium acetate (7.5 M) 
(Appendix C) was added to the sample, the mixture mixed by gentle inversion and left on 
ice for 10 min. Afterwards, 500 ml of (24:1) chloroform/2-pentanol (Appendix C) was 
added to the sample, and this was thoroughly mixed by multiple inversions. The mixture 
was then centrifuged for 10 min at 15.7 g. The DNA solution on the top of the two phase 
system was carefully removed without disturbing the thin layer of protein. An aliquot of 
the DNA solution (800 ml) was transferred into a new Eppendorf tube, and 0.54 volumes 
of ice-cold 2- propanol to precipitate the DNA. The sample was inverted slowly for one 
min and then centrifuged for another minute at 6.9 g. The supernatant was discarded and 
the pellet containing the genomic DNA was washed 5 times with 100 ml 70% ethanol, 
followed by centrifugation after each wash. The DNA pellet was finally dried and then re­
suspended in 30 ml TE buffer and stored at 4 °C until used.
2.2.2. Amplification of KatA gene fragments
This step was carried out to amplify the required gene (katA) using PGR.
The katA gene was amplified from genomic DNA of C. jejuni wild type NCTC 11168 
using the forward primer 5’- CATTACGTGCATCCCAGTGTTCTA-3’, designated as 
primer KatA 1 and the reverse primer
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5’- GGATCCGCTGCAAGCATAAGCAAGCTATCG-3’, designated as primer KatA 2 
yielding a product of 1425 base pair (bp).
A reaction volume of 100 pi was used for the PGR reaction and this was contained, 1 pi of 
genomic DNA (prepared as described above), 4 pi of each of the two appropriate primers 
at a concentration of 10 pM (Sigma, UK), 2 pi of dNTP’s at a concentration of 0.4 pM, 1 
pi of Taq polymerase (Go Taq Pol, 5 units), 20 pi of 5X buffer (Go Taq Buffer) and 69 pi 
of sterile distilled water. A mix of 100 pi of the PGR reaction was prepared as a negative 
control with no genomic DNA. The PGR reaction was performed using a PGR machine 
(Applied Biosystems) and the following program:
Initial dénaturation period of 5 min at 95°G 
Then 30 cycles of:
Dénaturation 95°G 45 sec
Annealing 55°G 45 sec
Elongation 72°G 3 min
After the 30 cycles there was a final extension period of 10 min at 72°G. The sample was 
then held at 4°G, and of 5 pi of amplified sample analysed by gel electrophoresis to 
determine whether the reaction had been successful.
2.2.3. DNA analysis by gel electrophoresis.
Gels were used primarily to visualize the products of reactions containing DNA such as 
enzymatic digestion, or to assess approximate DNA concentration. Unless otherwise stated 
these were used at a concentration of 1% w/v using a stock prepared by dissolving 1 g 
agarose in 100 ml 0.5X TBE. Ethidium bromide at a final concentration of 0.4 pg/ml was 
added to gels as they set. This stain enabled DNA within the gel to be visualized under 
exposure to long wavelength UV light. The gels were run in the same buffer at 40-100 Volt 
(V). DNA samples were prepared in water H2 O with DNA loading buffer at a final 
concentration of 0.1 v/v. An appropriate DNA ladder was used to assess size and 
concentration of DNA fragments.
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2.2.4. Ligation of the PCR product (katA) gene into pGEM-T easy vector.
The PCR product was cloned into pGEM-T Easy Vector System I (Promega, USA) as 
follows. 1 pi of the PCR product was added to the ligation mix containing 1 pi T4 DNA 
ligase (lU/pl), 5 pi 2x rapid ligation buffer, 1 pi of 20 ng plasmid DNA pGEM-T Easy and 
distilled water added to make the final volume of 10 pi. The reactions and a control (no 
PCR product) were then incubated at room temperature for 24 h. the KatA gene was 
inserted into the pGEM-T Easy cloning vector and the plasmid designated as pKatl and the 
resulting ligation mix was then used to transform E. coli DH5a as outlined below.
2.2.5. Transformation of plasmids into Escherichia coli DH5a using heat shock
A frozen aliquot of the competent cells obtained from the laboratory stock was defrosted 
on ice for 30 min prior to use. 10 pi of the ligation reaction or plasmid (pKatl) to be 
introduced into E.coli was added to 100 pi of the competent cells held in sterile Eppendorf 
tube and the mixture incubated for further 30 min on ice. Heat shock was applied by 
placing the tube in water bath set on 42°C for 1.3 min. One ml of LB broth was then 
aseptically added to the tube before incubation in water bath at 37°C for 1 h.
2.2.6 Selection of E. coli DH5a containing pKatl
To select for E. coli which had successfully taken up the plasmid, the cells were spread 
onto LB agar containing 100 pg/ml ampicillin, 1 ml X gal (16 pg/ml) and 1 ml of fPTG (1 
mM) and incubated at 37°C overnight. The pGEM-T Easy contains a gene for ampicillin 
resistance, therefore only colonies which had taken up the plasmid were able to grow. The 
plasmid also contains a lacZ gene which encodes j3-galactosidase, this enzyme metabolizes 
the chromogenic substrate X-gal resulting in a blue product. The cloning site for the PCR 
product lies within the lacZ gene, rendering it inactivate, thus X gal cannot be metabolized, 
resulting in white colonies. The white colonies there then selected and streaked onto LB 
agar supplemented with ampicillin and incubated overnight at 37°C.
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2.2.7. Purification of plasmid DNA pKatl using Mini prep Kit (Qiagen)
Purification of plasmids was carried out to give high yields of plasmid DNA (pKatl) at 
high purity, suitable for analysis by restriction digestion and PCR. 5 ml of LB broth with 
suitable antibiotic (100 pl/ml ampicillin) was inoculated with a loop full of E. coli in a 
sterile universal tube and incubated overnight at 37°C on a shaker at 250 RPM. An aliquot 
of this culture (1 ml) was transferred into a 1.5 ml Eppendorf tube and the cells were 
collected by centrifugation at 15.7 g after which the supernatant was discarded. 250 pi of 
cell re-suspension solution containing RNAase (10 mg/ml) was added to the pellet and the 
suspension vortexed. 250 pi of lysis solution was then added in order to lyse the cells, and 
the mixture was inverted and allowed to homogenize for less than 5 min to prevent 
genomic DNA from breaking down, which could result in chromosomal DNA 
contamination in the final recovered plasmid DNA. The lysate was then neutralized using 
350 pi neutralizing solution and inverted slowly several times. It was then centrifuged at 
15.7 g for 10 min. The supernatant containing the plasmid DNA was transferred to the 
binding column provided with the mini prep kit and centrifuged for 1 min at 15.7 g. The 
bound DNA was washed with ethanol solution before placing the QIA-prep silica 
membrane into a new 1.5 ml micro-centrifuge tube. The plasmid DNA was then eluted 
using 50 pi of low salt elution buffer, and stored at -20°C until needed. The plasmids 
containing the insert obtained were then tested on 1% agarose gels by mixing 5 pi of the 
eluted plasmid with 1 pi 6x loading dye buffer.
2.2.8. Digestion of the plasmid pJMK30 and isolation of the gene cassette for 
kanamycin resistance.
pJMK30 was grown on LB agar or LB broth supplemented with 50 pl/ml kanamycin. The 
plasmid was isolated from E. coli as described above and was digested using the restriction 
endonuclease BamYil (Roche) as two recognition sites for this restriction enzyme border 
the resistance cassette. In order to get sufficient DNA for isolation the digest was scaled 
up to include 20 pi of plasmid DNA (pJMK30). The resulting DNA fragments were 
resolved on a 1% agarose gel and the 1499 bp fragment comprising the kanamycin 
resistance gene was viewed on a UV box and cut out of the gel using a sterile scalpel. The 
agar was then placed into a pre-weighed Eppendorf tube and the Qia-quick gel extraction 
kit (Qiagen) was then used to extract the DNA from the gel, according to the 
manufacturer’s instructions.
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2.2.9. Insertion of the kanamycin resistance gene into the katA gene
A derivative of pGEM-T Easy Vector containing the cloned C.jejuni katA gene constructed 
in section 2.2.4 was named pKatl. This plasmid was purified and digested using the 
restriction endonuclease BgRl. There is a single site for this enzyme in pKatl in the centre 
of the katA gene. Bglil cleaves the DNA at the short recognition sequence A GATCT 
producing ‘sticky’ ends that are compatible with the BamYil ‘sticky’ ends of kanamycin 
resistance gene fragments. The reaction comprised of 1 pi DNA, 1 pi Bglil enzyme, 1 pi 
NE buffer (3) and distilled water to make the volume 10 pi, the reaction was incubated in a 
37°C water bath for E/4 h. A 1% agarose gel was run using 1 pi plasmid loaded with 1 pi 
loading buffer.
The kanamycin resistance gene fragment was cloned into pKatl using T4 DNA ligase 
(lU/pl) and for a successful cloning the ligation reaction required a ratio of 1:3 of vector to 
fragment. The appropriate quantities of vector, fragment, T4 ligase, 5x buffer and distilled 
water were put into Eppendorf tubes to make a volume of 20 pi. The reactions were mixed, 
and left overnight at 4°C. The resulting ligation reaction was introduced into E. coli DH5a 
as described above and selection for transformants made using LB agar plates containing 
50pl/ml kanamycin. A characteristic plasmid containing kanamycin resistance gene 
cassette inserted into the katA gene was designated as pMSl.
2.2.10. Plasmid MIDI prep of pMSl
To purify a large amount of plasmid DNA for transformation of Campylobacter a MIDI 
prep kit (Qiagen) was used. A culture of E. coli containing pMSl in 25 ml of LB broth 
containing kanamycin (5Op 1/ml) was prepared by overnight incubation at 37°C in a shaker 
with shaking at 250 RPM. The cells from this culture were harvested by centrifugation at 
5000 g for 15 min at 4°C and the supernatant were thrown away. The MIDI prep was then 
carried out according to the manufacturer’s instructions.
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2.2.11. Transformation of pMSl into C. y^yww/NCTC 11168
Cells from a MHA plate containing confluent growth of 48 h old C. jejuni NCTC 11168 
were harvested by added 1 ml of MH broth and scraping with a plastic spreader. The 
culture was centrifuged for 5 min at 4°C, and 15.7 g. The supernatant was discarded. To 
wash the pellet it was re-suspended in C. jejuni wash buffer (15% glycerol and 9% w/v 
sucrose) and then centrifuged for 5 min at 15.7 g, 4°C. This process was repeated 5 times. 
Aliquots of the cell mix (50 pi) were mixed with 1, 3, 4 pi of pMSl DNA in 1.5 ml 
Eppendorf tubes. All tubes were incubated on ice for 10 min. The plasmid pMSl was then 
transferred to chilled electroporation cuvettes (2 mm gap cuvette. Cell Projects, UK) for 
electroporated into competent C. jejuni wild type cells. High voltage pulses were delivered 
using a Gene Puiser apparatus (BioRad Gene Puiser). The pulse was adjusted to 2.5 kv, 
25F, 200 ohm to give a time constant of less than 4 seconds. After application of the pulse 
the cuvette was flushed twice with 100 pi SOC and cells then spread gently onto a non- 
selective MH agar plate. The plates were incubated at 37 °C for 5 h. Cells were then 
harvested from the recovery plates using 400-500 pi MH broth, and then plated onto dry 
MHA plates supplemented with 50 pg/ml kanamycin. To allow transformants to grow the 
plates were incubated for 2 to 5 days at 37°C under microaerophilic conditions. The 
genomic DNA of mutated katA gene was confirmed by PCR with primer Katl and primer 
Kat2 yielding the size of 2925 bp.
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CHAPTER 3 
RESULTS
3.1 Behaviour of C  jejuni in cows’ milk stored at various temperatures
As milk has been implieated in the transmission of Campylobacter infection (Simms & 
Mac Rae, 1989) an initial study was conducted investigating the growth or survival of the 
organism in milk stored at 4°C and 25°C. The results of the experiments carried out to 
establish and investigate this behaviour are presented in this chapter.
3.1.1 Recovery of C. jejuni by three different media; general, blood based and 
charcoal based media from laboratory contaminated milk at 4°C and 25°C.
An initial experiment was carried out to determine the appropriate medium for 
enumerating C. jejuni during survival studies when the sample was incubated under limited 
oxygen conditions (5% O2) at 4°C and 25°C. The recovery media were Mueller Hinton 
Agar (MHA), modified charcoal cefoperazone deoxycholate agar (mCCDA), and 
Skirrow’s Blood based medium (SKM).
Time (day)
Figure (2) Recovery of C. jejuni from sterile milk stored micoraerophilicaliy at 4°C (open symbols) and 25°C (closed symbols). 
Determined using MHA (♦ O ). mCCDA (■ □ )  and SKM (A A ), all media incubated at 37°C under microaerophilic conditions for 48h. 
Each point represents the mean logarithm of counts of the organism performed in duplicate and the arrows indicate sam ples where 
Campylobacter m s  not detected and the limit of detection.
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c. jejuni survived well at 4°C and recovery was almost the same for the three media tested. 
After 5 days incubation of the milk, mCCDA and SKM medium recovered the highest 
numbers of Campylobacters. The differences in counts between these two media were not 
considerable. The count declined < 1 log cycle from the initial inocula as determined using 
Skirrow’s and mCCDA and the differences in viability were 0.3 and 0.7 log cycles, 
respectively. On non-selective media (MHA) the viable number decreased >1.5 log cycles 
after the same period of incubation (Figure 2). The sensitivity of the three media at 25°C 
was approximately comparable. The initial count for C. jejuni was 7.5 log cfu/ml as 
determined in all three media (MFIA, mCCDA & SKM). After 1 day of incubation in 
sterile milk the count decreased sharply to 3.1, 3.4 & 3.2 log cfu/ml respectively. On day 3 
the count for C. jejuni on MHA, mCCDA & SKM were very similar at 1.5, 1.3 & 1.4 log 
cfu/ml respectively. C. jejuni was not detected on day 4 of incubation (Figure 2). Based on 
these initial experiments it was decided to use mCCDA as a recovery medium due to its 
easy preparation and it being economically cheaper.
3.1.2 Survival of C. jejuni survived in UHT milk compared with pasteurised 
milk at 4°C and 25°C
Tlme(h)
Figure (3) Effect of temperature on survival of C. jejuni strain (NCTC 11168) incubated aerobically at 4°C and 25°C in UHT and 
pasteurized skimmed milks. . Pasteurized (4"C) (A),  ÛHT (4“C) {□), pasteurized (25°C) (A) and UHT (25X) (■) skimmed milk. Each 
point represents the mean logarithm of the counts of the organism performed in duplicate and the arrows indicate samples where 
Campylobacter was not detected and the limit of detection.
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Initially, strain NCTC 11168 of C. jejuni was tested for its ability to survive at 4°C and 
25°C in pasteurized and UHT milk in the presence of air. The culture survived best in UHT 
milk at refrigeration temperature with a decrease of < 0.5 log cfu/ml over 5 days of 
incubation. In contrast, in pasteurized milk incubated aerobically, the strain of C. jejuni 
decreased in viability 5 log cfu/ml by day 5. Given the similar conditions of atmosphere, C. 
jejuni died substantially more rapidly in pasteurized compared to UHT milk at 25°C, as 
illustrated by the results shown in (Figure 3). The viable count of the organisms declined 
by 3 log cycle over 3 days in UHT milk, whereas, in pasteurized milk the bacterial 
population decreased by > 7 log cycle to below the detection limit after only 2 days of 
incubation.
This suggests that there is a bactericidal factor that is killing C. jejuni in pasteurized milk 
which is absent, or at least much weaker, in UHT skimmed milk. The difference between 
the two types of milk is the heat treatment that they receive during their processing and the 
sterile packing environment used in UHT processing. This could mean that pasteurised 
milk may have a residual thermoduric flora and/or contaminants introduced after heating. 
Pasteurized milk could also retain more heat sensitive milk components due to the lower 
temperatures used in pasteurization. Either, or both, of these explanations could be the 
cause of the observed enhanced sensitivity of C. jejuni seen in pasteurised milk.
3.1.3 The natural microflora in pasteurized milk has no effect on the survival 
of C. jejuni 11168 at 25°C.
To determine whether the contaminating microflora in pasteurised milk was responsible 
for the observed effect, Campylobacter survival in pasteurised milk which had been filter 
sterilised using 0.45 pm and 0.22 pm filters was compared with normal pasteurised milk 
and a milk that had received a commercial filtration process (Cravendale) to reduce the 
microflora below the level normally achieved by pasteurisation alone. The survival o f C. 
jejuni at 25°C in Cravendale milk is shown in (Figure 4). It can be seen that the C. jejuni 
shows a similar survival curve whether inoculated into pasteurized milk or Cravendale 
milk and <1 log reduction in viable count was noticed after 6 h. Campylobacter became 
non-culturable in both milk types by 24 h of incubation. In comparison, survival of C. 
jejuni in UHT milk (as a control) was better and the decline in viable count was 2.6 log 
cfu/ml over a period of 30 h. C. jejuni exhibited similar survival behaviour as in unfiltered
58
pasteurized milk (Figure 5) In both samples the count decreased by more than 3 log cfu/ml 
after 9 h of incubation and to below the detection limit after 24h.
Table 5 shows the initial total viable counts in unfiltered, filtered and Cravendale 
pasteurized milk. The results show the total viable count to be much higher in unfiltered 
pasteurized milk (2.68 log cfu/ml), in comparison to the filtered and Cravendale milk 
which showed a count of 5 cfu/ml and undetectable, respectively. Although the normal 
microflora was almost absent in the last two types of milk, the behaviour of 
Campylobacter was similar to that seen in normal pasteurised milk This suggests that the 
killing factor in pasteurized milk is not the normal bacterial micro-flora. This conclusion 
was supported by an experiment in which the growth of the competitive micro-flora in 
pasteurised milk was monitored during incubation at 37°C (Figure 6). The graph shows 
that no growth took place in pasteurized milk over the first 24h and numbers remained low. 
Though the bacteria did start to grow rapidly after that, the effect on Campylobacter 
occurred during the first 24h during which the competitor numbers were low, supporting 
the observation that the micro-flora did not kill Campylobacter.
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Figure (4) Survival C. jejuni in pasteurized (▲) UHT (■) and Cravendale ( • )  skimmed milk incubated aerobically at 25°C Each point 
represents the mean logarithm of the counts of the organism performed in duplicate and the arrows indicate samples where 
Campylobacter w as not detected and the limit of detection.
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Table (5) Total viable bacterial counts in un filtered, filtered and Cravendale pasteurized milk
Type of Milk Total Viable Counts (log cfu/ml)
Un-filtered milk 26 8
Filtered milk 0.698
Cravendale milk < Limit o f Detection (<10 cfu/ml)
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Figure (5) Survival of C. jejuni in untreated (▲} and filter sterilised (O) pasteurized skimmed milk, incubated at 25°C under aerobic 
conditions. Each point represents the mean logarithm of the counts of the organism performed in duplicate and the arrows indicate 
samples where Campylobacter was not detected and the limit of detection.
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Figure (6) Growth of total viable count (TVC) from pasteurized skimmed milk during aerobic incubation at 37°C. Each point represents 
the mean logarithm of counts of the organisms performed in duplicate.
3.2. The natural antimicrobial lactoperoxidase is responsible for the 
killing of Campylobacter in milk
Since the milk micro-flora did not appear to be involved in killing Campylobacter a 
ehemical eonstituent of the milk must be responsible. Milk does contain low
concentrations of a number of antimicrobial components that protect either neonates or the 
udder from infection. Though the level of these antimicrobials in cow’s milk is low, they 
have a marked effect on its keeping quality and safety (Adams & Moss, 2008). In view of 
the difference seen between pasteurised milk and UHT milk a possible candidate for the 
antimicrobial factor responsible for the observed effeet would be a heat labile protein. 
Laetoperoxidase see (section 1.12) is one possible candidate and its possible involvement 
was investigated by comparing survival in pasteurised milk samples whieh had been boiled 
to inactivate residual enzyme activity or to which an inhibitor of lactoperoxidase had been 
added, sodium meta-bisulfite (Na2S2 0 5 ), (Figure 7).
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Figure (7) Survival of C. jejuni in untreated pasteurized skimmed milk (control) (A), in pasteurized skimmed milk with 1 mM sodium meta­
bisulphite (Na^SgOg) (A),  in UHT skimmed milk with 1 mM sodium meta-bisulphite (NajSjOj) (■) and in boiled pasteurized milk (c), 
incubated at 25^C under aerobic conditions. Each point represents the mean logarithm of counts of the organism performed in duplicate 
and the arrows indicate samples where Campylobacter was not detected and the limit of detection.
1 mM of sodium meta-bisulphite (Na2S2 0 5 ) was used to inhibit the lactoperoxidase 
enzyme and this was found to markedly enhance the survival of C. jejuni in pasteurized 
skimmed milk when incubated aerobically at 25°C. The same inhibitor when used in UHT 
skimmed milk had no appreciable effect on survival.
Campylobacter survived better in pasteurized milk treated with Na2S2 0 5  than in the control 
with an approximate decrease of 4 log cycles over 48 h aerobic storage at 25°C compared 
with a more than 7 log drop in the untreated control over 24 hours (Figure 7). A similar, 
but more pronounced effect was seen in the pasteurised milk sample which had been boiled 
and the count declined by only 2.3 log cycles. In the pasteurized milk sample the organism 
did not survive more than 6 h with a decrease in count of 7 log cfu/ml after this point.
In the treated pasteurized milk, Campylobacters showed similar survival compared to UHT 
milk treated with Na2S2 0 5 , where C. jejuni survived up to 48 h with the reduction rate < 3 
log cfu/ml at this point (Figure 7).
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The similarity between the survival curves in UHT and pasteurised milk samples 
containing Na2 S2 0 5  indicates that the meta-bisulphite had neutralised whatever was 
responsible for the difference seen between the two types of milk. As meta-bisulphite 
protected C. jejuni in pasteurized milk but gave no protection in UHT milk, it would seem 
that the killing in pasteurized milk is due to lactoperoxidase and that meta-bisulphite 
inhibited this enzyme.
As hydrogen peroxide is required for the lactoperoxidase activity in milk, it is possible that 
addition of exogenous catalase, which converts this compound to water and oxygen, would 
destroy the hydrogen peroxide required by the lactoperoxidase and thereby enhance 
Campylobacter survival in pasteurized milk. The effect of the addition of catalase in 
different concentrations was assessed as shown in (Figure 8). At 25°C exposure of C. 
jejuni in pasteurised skimmed milk to 100 units/ml and 500 units/ml of catalase enzyme 
enhanced the survival of the organism and the reduction in bacterial count was <1.5 log 
cfu/ml and < 1 log cfu/ml, after 6 h, respectively, compared to the control sample (catalase 
absent) where the reduction was > 5 log cfu/ml, during the same period of incubation. 
Viable cells were not detectable after 23 h. Increasing the concentration of the catalase 
enzyme to 1000 units/ml in pasteurized milk, increased the survival of the organism so that 
it was still detectable at 46 h with a steady decrease in count from initial level of 6.7 log 
cfu/ml to 1.2 log cfu/ml, at the end of the incubation period.
This observation suggests that the presence of hydrogen peroxide, perhaps from bacterial 
metabolism, is important for lactoperoxidase to be activated.
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Figure (8) Survival of C, jejuni NCTC 11168 in pasteurized skimmed milk In the presence or absence of catalase. Pasteurized 
skimmed \was incubated aerobically at 25 °C with no addition (A),  with 100 units (A), 500 units ( ) and 1000 units (■ ) of catalase 
added. Each point represents the mean logarithm of counts of the organism performed in duplicate and the arrows indicate samples 
where Cam pylobacter was not detected and the limit of detection.
To confirm that it was active against Campylobacter, the lactoperoxidase (LPO) system 
was prepared in the laboratory using sodium perearbonate as a hydrogen peroxide souree, 
sodium thiocyanate and lactoperoxidase enzyme aceording to the FOW/WHO guidelines 
(FOW/WHO, 2005). The survival of C. jejuni in UHT skimmed milk to which the LPO 
system had been added was then investigated and is shown in (Figure 9). The presenee of 
the LPO system in UHT milk enhanced the inaetivation of C. jejuni whieh deereased in 
viable numbers by more than 4 log elu/ml after just 3 h of ineubation. Viable cells were 
undeteetable (> 7 log reduction) after 6 h. When the enzyme inhibitor Na]S2 0 5  was also 
present, the effect of the LPO system was totally removed and the eounts of the 
campylobaeters deereased by only about 2 log cycles over 28 h, showing a very similar 
profile to the UHT only eontrol.
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Figure (9) the affect of a reconstituted whole LPO system on the survival of C. jejuni NCTC 11168 in UHT milk. UHT milk with no LPO 
(■), with the reconstituted LPO system (□) and with the reconstituted LPO system and the inhibitor Na^SgO; (A), was incubated 
aerobically at 25°C, Each point represents the mean logarithm of counts of the organism performed in duplicate and the arrows 
indicate samples where Campylobacter was not detected and limit of detection.
The antimicrobial activity of each individual component of the LPO system (LP-SCN'- 
H2O2) against C. jejuni in UHT milk was also investigated (Figure 10). The behaviour of 
C. jejuni was constant in all samples treated with each component individually for 6 h. 
However, the bacterial count in the sample treated with both LP & H2 O2 decreased by 
almost 1.5 log cfu/ml after the same period. After 29 h of incubation the greatest inhibitory 
effect was observed in milk treated with the combined components and C. jejuni was not 
detected. With individual components however the viable count reduced from its initial 
level to 4.2, 3.8, 6.6 and 4.5 logs in untreated UHT, H2 O2 only, SCN' only and LP only, 
respectively over the same period. This indicates that the UHT treatment has 
inactivated/reduced both the LP enzyme and endogenous hydrogen peroxide production 
since both are necessary for maximum activity.
65
Time (h)
Figure (10) Survival of C. jejuni 11168 in milk to wfiich different components of the LP-system had been added. Control no addition 
(■), LP + H2 O2  (A), HjOj only (O), SCN only ( ) and LP only (♦), incubated aerobically at 25°C. Each point represents the mean 
logarithm of counts of the organism performed in duplicate and the arrows indicate samples where Cam pylobacter was not detected 
and limit of detection.
Clearly the lactoperoxidase system when added to UHT milk had a pronounced effect on 
the survival of Campylobacter. To further investigate whether residual endogenous LPO 
activity was involved in pasteurized skimmed milk, the concentrations of thiocyanate ion 
and the level of lactoperoxidase in different types of milk were measured and are given in 
(Table 6).
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Table (6) Thiocyanate concentration and lactoperoxidase activity in different types of pasteurized and 
UHT skimmed milk obtained from a local supermarket (w=7±SD)
Milk Type SCN-(Mg/ml) LPO activity (U/ml)
Tesco pasteuiized skiiiuiied milk 0.189 +0.04 0.535 ±0.11
Tesco organic pasteurized skimmed 
milk 0.197 ±0.002 0.323 ±0.09
Cravendale pasteuiized skimmed milk 0.168 ±0.03 0.421 ±0.08
Tesco value UHT skimmed milk 0.140 ±0.002 0.177 ±0.05
BritishUHT .skimmed milk 0.158 + 0 0.199±0.01
Pure milk slimmer UHT skimmed milk 0.117 + 0.002 0.169 + 0.10
Pasteuiized Camels’ milk 1.059 ±0.01
LP = lactoperoxidase, SCN'= thiocyanate, SD =standard deviation
Pasteurized skimmed milks have higher thiocyanate content and lactoperoxidase activity 
than UHT skimmed milks. Types of milk within the same kind of process (pasteurized or 
UHT) did not differ much. This observation further supports the role of LPO in the 
observed effect on survival of Campylobacter in pasteurized milk.
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3.3 Survival of C. jejuni in comparison with other food borne pathogens 
and other strains of Campylobacter jejunilcoli in UHT and pasteurized 
milk.
Aerobic organisms such as Salmonella Enteritidis, Listeria monocytogenes and E. coli 
0157:H7 must also deal with reactive oxygen species to avoid oxidative damage. 
However, microaerophilic organisms are generally more sensitive to oxidative stress. Thus 
an experiment was carried out in pasteurized and UHT milk to determine whether the 
lactoperoxidase also impacted on the survival of aerobic food-borne pathogens. In (Figure 
11 A) the survival of S. enteritidis, L. monocytogens and E. coli 0157:H7 were seen to be 
almost parallel and they grew from approximately 6.7 logio cfu/ml to 8 logio cfu/ml, over a 
period of 25 hrs, showing that aerobic food-borne pathogens are resistant to the 
lactoperoxidase present in milk. In contrast, C. jejuni was markedly more sensitive and was 
not detectable after 9 h in pasteurized skimmed milk.
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Figure A) Survival of C. jejuni (A), Salmonella enteritidis ( ), L m onocytogenes (□) and E coll 0157 H7 non-toxigenic (A), in 
pasteurized skimmed milk, incubated aerobically at 25°C. Each point represents the mean logarithm of the counts of the organisms 
performed in duplicate and the arrows indicate samples where Campylobacter w as  not detected and the limit of detection.
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When the survival of the different bacterial pathogens was assessed in UHT milk all, with 
the exception of Campylobacter, showed similar growth and increased from approximately 
6.7 log to 8.5 log by the end of the incubation period, similar to what was seen in 
pasteurized skimmed milk (Figure 1 IB). In contrast, C. jejuni showed a reduction in 
population count from 6.4 logio cfu/ml to 4.8 logic cfu/ml over a period of 48 h, due to its 
sensitivity to the oxygen exposure.
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Figure (11B) Survival of C. jejuni (■), Salmonella enteritidis ( ), L. monocytogenes (□) and E. coll 0157:H7 non-toxic (A), in UHT 
skimmed milk, incubated aerobically at 25"C Each point represents the mean logarithm of counts of the organisms performed in 
duplicate.
Since C. jejuni and C  coli are the two main species that cause gastrointestinal illness in 
humans and animals, the effect of the lactoperoxidase enzyme on two strains of both 
species was evaluated and studied in pasteurized and UHT skimmed milk held at 25°C. 
Survival of all strains in pasteurized milk varied greatly (Figure 12 A). For example, strains 
of C. jejuni NCTC 11168 and 11828, showed a reduction of approximately 4 logic cfu/ml 
after 6 h, to undetectable after 23 h, whereas strain of C. coli NCTC 1211, illustrated a 1 
logic cfu/ml decrease in the bacterial counts after 6 h to undetectable after 26 h. 
Interestingly, one strain of C. coli NCTC 11350, was still detectable with 1.6 logic cfu/ml 
at 48 h after ineubation.
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Figure (12A) Survival of C. jejuni strain NCTC 11168 (A), NCTC 11828 (A) and C. coli strains NCTC 12110 (♦), NCTC 11350 (□) in 
pasteurized skimmed milk, incubated aerobically at 25°C. Eacti point represents the mean logarithm of counts the organisms performed in 
duplicate and the arrows indicate samples where Campylobacter was not detected and limit of detection.
In UHT skimmed milk, survival was greatest with C. jejuni strain 11168 and lowest with 
C. coli strain 12110 (Figure 12B). After 48 h at 25°C, very little death oeeurred with 11168 
with a reduction of < 1 logio cfu/ml, whereas the reduction in the viable count of strain 
12110 was > 5 logic efu/ml, over the same period. The survival of strain 11828 was less 
than but paralleled to the survival of strain 11350 over the 48 h.
Since there were some differences in the survival of C. jejuni strains and C. coli strains 
especially in pasteurized skimmed milk, a further experiment with 10 more strains of C  
jejuni and 11 strains of C. coli in pasteurized and UHT skimmed milk at 25°C was carried 
out to confirm this observation. The further experiments showed that there were no 
significant difference in the behaviour of C. jejuni and C. coli strains either in pasteurized 
or UHT skimmed milk. All strains were not detected after 6 hrs in pasteurized skimmed 
milk and the survival of strains remained up to 48 hrs in UHT milk (data not shown).
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Figure (12B) Survival of C. jejuni strain NCTC 11168 (A), NCTC 11828 (A) and C am pylobacter coli strains NCTC 12110 (♦ ), 
NCTC 11350 (□ ) in UHT skimmed milk, incubated aerobically at 25°C. Each point represents the mean logarithm of the counts of 
the organisms performed In duplicate and the arrows indicate samples where Cam pylobacter was not detected and the limit of 
detection.
3.4 Behaviour of C. jejuni in camel’s milk at 4°C and 25°C in aerobic 
condition.
The behaviour of C. jejuni was tested in the milk of UAE’s indigenous camels at 4°C and 
25°C. In (Figure 13), it can be seen that the viable eounts of C. jejuni in pasteurized and 
boiled camel’s milk were almost constant showing no significant change at both 
temperatures. This is in contrast to the previous findings in cow’s milk where the 
laetoperoxidase system led to a rapid death of C. jejuni in pasteurized skimmed milk when 
incubated aerobically at room temperature. These results suggest that the lactoperoxidase 
enzyme exist in camel’s milk had no effect on the survival of C. jejuni.
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Figure (13) Survival of C. jejuni 11168 in ordinary pasteurized camel’s milk at 4°C (A ) trailed pasteurized camel's milk at 4°C (□), 
ordinary pasteurized camel's milk at 25°C (A) and trailed pasteurized camel's milk at 25°C (B), incubated aerobically.
This study also examined and evaluated the microbiologieal status of raw camel milk from 
camels of UAE origin. All possible precautions were taken to avoid any contamination of 
the milk. The bacteriological results found were compared with milk parameters of "raw 
cow milk intended for direct human consumption” aceording to EU standards (Total 
Bacterial Count) (Anonymous, 2004) and “Certified raw cow milk” according to German 
regulations (Coliforms) (Anonymous, 2000), as no raw camel milk standards are available.
3.4.1. TVC
The quality of the milk collected from Emirates Industries for milk and dairy products was 
assessed for the carriage of Campylobacter and other microbial indices of quality.
The aerobic plate count is an indication of the sanitary conditions under whieh the food 
was produced (Omer and Eltinay, 2008). The Total Viable Count (TVC) values may range 
from <10^ cfu/ml to 1 x 10^  cfu/ml of milk, with counts of more than 10  ^ cfu/ml being 
proof of serious faults in production hygiene, whilst counts of less than 20,000 cfu/ml 
reflecting good hygiene practices (International Dairy Federation, 1974).
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In this study the means of TVC and the ranges of bacterial counts of the camel’s raw milk 
are shown in (Table 7). The total viable count varied from 1 x 10^  to 2.9 x 10"^  cfu/ml with 
an average of 3.4 x 10^  cfu/ml. Out of 109 samples tested for TVC, 40 samples (38%) were 
found to contain bacterial counts in excess of 10^  cfu/ml, and 100 % of samples showed 
total bacterial counts lower than 10  ^cfu/ml, and these counts are within the limits set by 
the European Union (EU) Standard Commission for raw cow’s milk (Anonymous, 1992). 
According to the EU standard, if TBC >1x10^ cfu/ml.the milk sample is considered 
unacceptable for human consumption.
Table (7-A) Mean counts (cfu/ml) of Total Viable Count (TVC)
Organi.sni
Niinibei of
::t:-:::ygample:rCy
Range of TVC (cfii/nd) Mean (cfii/nd) SD
Total Mable Count 109 1x10^-2.9x10'» 3.4x105 2.5x105
Table (7-B) Mean counts (loglO) of Total Viable Count (TVC)
Organism
Nunibei of 
.sample
Range of H  C  (logl 0) Mean(loglO) SD
Total Viable Count 109 2-4.46 3.23 1.74
3.4.2. Coliforms, Escherichia coli and Salmonella
No coliforms, E. coli, or Salmonella were isolated from the milk samples examined from 
66 clinically healthy dromedaries of UAE breed which had no signs of mastitis.
3.4.3. Campylobacter spp.
No Campylobacter was isolated from the 171 milk samples assessed for their presence
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3.5 Xanthine Oxidase (XO) natural enzyme in milk has a minor effect on 
killing C. jejuni
Xanthine oxidase (XO) is another natural antimicrobial system found in milk of various 
origins (Stevens, et. al., 2000). Oxypurinol is an inhibitory substrate for XO enzyme and 
was used to determine whether the survival of C. jejuni in pasteurized milk was due to XO. 
At 25°C, in pasteurized skimmed milk, exposure of C. jejuni to a concentration of 25 pM 
of oxypurinol did not enhance the survival of organism and the viable count remained 
constant after 6 h, and was undetectable after 9 h, similar behaviour was seen in the control 
sample to which no inhibitor had been added (Figure 14). However, exposure the organism 
to higher concentrations of oxypurinol 100 and 200 pM intially resulted in a slight 
reduction in viable count of 1.5 and 1.24 log cfu/ml but extended the time for which 
Campylobacters were recoverable to 9 h of incubation. At this point C. jejuni was not 
detectable in the absence of oxypurinol but was detectable when this agent was present. 
This result suggests that xanthine oxidase might have a minor or indirect effect on killing 
C. jejuni in pasteurized milk.
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Figure (14) Survival of C. jejuni in pasteurized milk in the presence or absence of the XO inhibitor oxypurinol. Cells of C. jejuni NCTC 
11168 were incubated aerobically in the absence of oxypurinol (A), or in the presence of 25 pM (A ),100 pM oxypurinol (♦ )  and 200 
pM ( ), of this compound at 25°C. Each point represents the mean logarithm of the counts of the organism performed in duplicate 
and the arrows indicate samples where Campylobacter was not detected and the limit of detection
To further elucidate the role of xanthine oxidase, the enzyme was added at a concentration 
of 30 mg/1 to UHT skimmed milk that had been inoculated with C. jejuni so that its action 
could compare to LPO. The presence of XO had little effect on the survival profile (Figure 
15) whilst the LPO system resulted in a decrease of more than 4 log cycles in the viable 
cells of C. jejuni in 3 hours. This suggests that C. jejuni is very sensitive to the LPO system 
and that XO has no direct killing effect on the organism in the skimmed milk.
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Figure (15) Survival of C. jejuni in UHT milk control (■), XO (A) and LPO system (□), incubated aerobically at 25°C, Each point 
represents the mean logarithm of the counts of the organism performed in duplicate and the arrows indicate samples where 
Cam pylobacterwas not detected and the limit of detection.
3.6 The contribution of oxidative and nitrosative stress defence systems in 
the response of C. jejuni to lactoperoxidase.
As the LPO system brings about the killing of baeteria via short lived oxidized 
intermediates, and requires hydrogen peroxide for activity, it was decided to determine 
whether mutants of C. jejuni deficient in various aspects of the oxidative defence showed 
altered resistance to this system. As the key aspects of the defence against oxidative stress 
in Campylobacter, are superoxide dismutase (Pesei, et. al., 1994) and catalase (Grant and 
Park, 1995), it was decided to assess mutants deficient in these enzymes in comparison 
with the parental strain. A sodB mutant deficient in superoxide dismutase is already 
available (Purdy and Park, 1994 and K. Elvers, unpublished data), but whilst a katA mutant 
has been made in C. coli (Grant and Park 1995), none is available in strain NCTC 11168, 
and it was thus necessary to construct a mutant of this strain as detailed below. Finally, the 
survival of a mutant deficient in Cgb, the major component of the nitrosative stress defence 
of C. jejuni (Elvers et. al., 2004) was characterized to determine whether the production of 
nitrosative stress via XO (Ungvari, et. al., 2005) had any influence on the survival of 
campylobaeters in pasteurized milk.
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3.7 Constructing of katA mutant from C. jejuni strain (11168)
The katA gene of C. jejuni NCTC 11168 was amplified using the oligonucleotide primers 
KatAl and KatA2 as stated in (section 2.2.2). The amplification of the KatA gene by PCR 
yielded a clear single band corresponding approximately in size to the predicted size of this 
fragment, 1425 bp (Figure 16).
M
1425 bp
Figure (16) 1 % agarose gel showing the PCR product from the amplification of the C. je ju n i N CTC  11168, 
katA  g en e  by PCR using specific primers. (Lane M) 1000 bp DNA m olecular weight marker. (Lane 1) 
control sam ple without target DNA. (Lane 2) PCR product 1425 bp using katA  specific primers.
The katA gene fragment was cloned into the pGFM-T easy vector (pKatl). The ligation 
was mix transformed into competent cell E. coli (DH5a) and transformants selected for 
resistance to ampicillin. Cells with inserted vector (white colonies) were chosen and plated 
on to LB agar supplemented with ampicillin. The cells containing plasmids with inserts 
had white colonies due to the inactivated B-galaetosidase gene. Plasmid DNA purification 
was carried out using Mini-prep kit. Six colonies were selected and the plasmids contained 
within purified using the Mini-prep kit. The purified plasmids containing the katA gene 
were digested with BglW digestion enzyme. The resulting single linear fragment should be 
bigger than the size of vector alone whieh is approximately 3000 bp. As can be seen in 
(Figure 17), the plasmids with inserts have a single BglW site derived from the inserted
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katA gene and these linearise to a single band of 4425 bp. One sueh plasmid containing the 
cloned katA gene was designated as pKatl.
M
4425 bp
Figure (17) 1% agarose  gel showing the vector pGEM-T ea sy  with inserted ka tA  g e n e  fragment, and 
mi ni prep of se lected  colonies from LB agar plate with ampicillin (Lane M) 1000 bp DNA m olecular weight 
marker, (Lane 1-5) the vectors containing the insertion of the KatA  g en e  fragments cut with Sg/ll (Lane 6) 
thepGEM -T e a sy  vector which is not d igested  by Bg/ll and rem ains supercoiled.
3.7.1. Insertion of kanamycin resistance cassette into katA
Digestion of pJMK30 with BamHI liberates a band of approximately 1500 bp which 
contains a kanamyein-resistanee cassette, and 3000 bp fragment that represents the plasmid 
backbone fragment (Figure 18). Digestion of pKatl with BglW generates a linear fragment 
of around 4425 bp This linear form of pKatl was ligated with the gel purified 1500 bp 
BamHI frtàgmQnX from pJMK30.
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Figure (18) Agarose gel 1% showing digested plasmids. (Lane M) 1000 bp DNA molecular weight 
marker (Lane 1) pKat1 digested with Bgfll (4425 bp). (Lane 4,5,7 & 8) digested pJMK30 with BamHI. 
the kanamycin cassette product (1500 bp) and the plasmid backbone (3000 bp).
The ligation was introduced into E. coli DH5a by transformation and kanamycin resistant 
transformants selected. Plasmids from three such transformants were purified by Mini-prep 
and analysed by gel electrophoresis as seen in (Figure 19). All transformants (Lanes 1-3) 
showed that kanamycin cassette had been successfully ligated into the pKatl plasmid as 
the sizes of the plasmids from the transformants are larger than pKatl. The new 
constructed plasmid was named (pMSl).
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Figure (19) 1% agarose gel showing the purified constructed plasmid pM Sl from miniprep. (Lane M) 
1000 bp DNA molecular weight marker. (Lanes 1-3) plasmid from kanamycin resistant transformants. 
(Lane 4) uncut pKat I .
PCR was used to determine the orientation of the kanamyein cassette in pMSl. The 
orientation of the specific KatA primers is shown in (Figure 20). The generated PCR 
product illustrated the band size of KatA plus the kanamyein cassette (2925 bp). This 
confirms the disruption of the KatA gene with the kanamycin cassette, thus confirming the 
genotype of the mutated strain (pMSl). Samples in (Figure 20) also shows fragment of the 
PCR plasmid plus the KatA gene (pKatl, 4425 bp) and the PCR product of wild type strain 
(1425 bp) acts as eoi
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Figure (20) The PCR products showing the orientation of the kanamycin resistant cassette  in pKatl 
derivatives and the control samples used. (Lane M) 1000 bp DNA molecular weight marker. (Lane 1- 
3) PCR product with KatA and kanamycin cassette using specific KatA primers. (Lane 4 & 5) non 
specific band and no PCR product respectively. (Lane 6) PCR product of genomic DNA for wild type 
C. je juni (Lane 7) PCR product of pKatl.
3.7.2. Construction of a C. jejuni KatA mutant using the suicide plasmid pMSl
To construct a C. jejuni KatA mutant, the suicide plasmid pMSl was purified using Midi- 
prcp and then introduced into competent cells of C. jejuni NCTC 11168 by electroporation. 
Only cells, which had taken up the plasmid, were able to grow on MH agar supplemented 
with 50 g/ml kanamycin as pMSl contains a gene, which encodes for kanamycin 
resistance, thus enabling selection of the C  jejuni KatA mutant. The genotype of two 
kanamycin resistant transformants was assessed using PCR primers specific for KatA gene 
and they arc KatA 1 andYeàtA 2 (section 2.2.2) as seen in (Figure 21). The chromosomal 
DNA of two transformants yielded bands consistent with the insertion of the 1500 bp 
kanamycin resistance cassette and were thus katA mutants. The mutants were also assessed 
using a simple catalase test (exposure of the colonics to 3% H2 O2 ) and as expected whilst 
the wild-type strain was catalase positive the mutant strains were catalase negative (data 
not shown).
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Figure (21) A gel electrophoresis using 1% agarose gel strained with ethidum bromide showing PCR products of 
plasmid pKatl and pMS1 using specific KatA primers Kat1 and Kat2. (Lane M) 1000 bp DNA molecular weight 
marker. (Lane 1) A (1425 bp) PCR product from pKat1 confirming the insertion of the KatA  g en e  fragment into 
the plasmid. (Lanes 2-4) target DNA from putative KatA mutants, which indicates that pMSI contained a 
kanamycin fragment (1500 bp) inserted into the KatA  fragment of pKat1.
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The contribution of the catalase enzyme, encoded by katA, in the oxidative stress resistance 
of C. jejuni and to its response to the residual lactoperoxidase in pasteurised milk was 
assessed.
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Figure (22) Survival of Campylobacter jejuni wM  type in UHT milk control (■), in Pasteurized milk control (♦ ). and the survival of the katA 
mutant in UHT milk (□ ) and Pasteurized milk (A), incubated aerobically at 25°C Each point represents the mean logarithm of the counts 
of the organism performed in duplicate and the arrows indicate samples where Campylobacter was  not detected.
When cell survival was assessed under aerobic conditions in pasteurized skimmed milk, 
the number of recoverable wild-type cells declined sharply by a factor of 4.6 log cycles in 
6 h to undetectable levels after 9 h of incubation at 25°C (Figure 22). The katA mutant 
possessed survival characteristic similar to those of the parental strain with a reduction of 
3.9 log efu/ml after same 6 h incubation period. In UHT milk the counts of the wild type 
decreased steadily, and had fallen by 1.7 log cycles by the end of the incubation period. 
The katA mutant again exhibited similar survival characteristics to those observed for the 
wild-type strain.
In order to assess the contribution of several other systems involved in the resistance to 
oxidative/nitrosative stress, survival of mutants of C. jejuni deficient in catalase {katA), 
superoxide dismutase (sodB) and the nitrosative stress response (cgh) (section 1.5.7), was 
assessed in pasteurised and UHT milk incubated aerobically at 25°C. The absence of the 
key enzymes in the mutant cgb, sodB and katA did not reduce the ability of C. jejuni to
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survive in pasteurized milk since they had survival rates better to that of the wild type 
strain (Figure 23A). The viable count of the cgb and sodB mutants reduced by 4.4 and 4.3 
cycles after 9 h, respectively, whilst the katA mutant declined in viable count by 1.9 log 
cycles after the same period of time. All mutants were undetectable after 25 h of 
incubation. The behaviour of the parental strain was different as the population of the 
organism reduced by 1 cycle after 6 h and was undetectable after 9 h. In UHT milk (Figure 
23B) the survival of each mutant varied greatly over a period of 25 h in comparison to the 
wild type C. jejuni which reduced by < 1 log cfii/ml after 9 h and the organism was not 
detectable after 25 h. The catalase deficient mutant and superoxide dismutase mutant 
showed more sensitivity in UHT milk and the reduction in viable count was almost 4 
cycles over 25 h of incubation. In comparison, the nitrosative stress deficient cgb mutant, 
showed increased survival with a reduction in count by 1.5 cycles over the entire 
incubation time.
When cell survival of the same mutants was assessed under the same aerobic conditions 
but in MHB, the recoverable viable count of wild type, katA mutant and sodB mutant cells 
decreased by 3, 1.9 and 2.5 log cycles after 25 h of incubation at 25°C, respectively (Figure 
23C). In contrast, counts of the nitrosative stress mutant declined by < 1 cycle within the 
first 6 h of incubation, but were undetectable by 25 h.
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Figure (23A) Survival of wild type C, jejuni (▲) in comparison with cgb  (♦), sodB  { • )  and KatA (A) mutants in pasteurized skimmed milk 
incubated aerobically at 25°C. Each point represents the mean logarithm of counts of the organism performed in duplicate and the arrows 
indicate samples where Campylobacter was not detected.
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Figure (23B) Survival of wild type C, jejuni (A) in comparison with cgb  (<'), sodB  ( • )  and KatA (A) mutants in UHT skimmed milk 
incubated aerobically at 25°C. Each point represents the mean logarithm of counts of the organism performed in duplicate and the arrows 
indicate samples where Campyiobacter was not detected.
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Figure (23C) Survival of wild type C. jejuni (A) in comparison with cgb (♦), sodB  ( • )  and KatA (A) mutants in MHB incubated aerobically 
at 25°C. Each point represents the mean logarithm of counts of the organism performed in duplicate and the arrows indicate samples 
where Campylobacter was not detected.
3.8. Application of the LPO system from pasteurized milk as a potential 
natural antimicrobial against Campylobacter on chicken skins and 
surfaces.
The potential for practical use of the antibacterial activity of the lactoperoxidase system 
(LPO) against Campylobacter was tested on artificially contaminated surfaces. Exposure 
of C. jejuni to the LPO system on filter membranes at 25°C reduced the viable count 
significantly to below the detection limit after just 3 h incubation (Figure 24), whilst the 
sample treated with pasteurized milk showed gradual decline in the viable count 
approximately 3.5 log cfu/ml over a period of 24 h. In comparison, in the control sample 
(water) the bacterial population remained at an almost constant level up 24 h. This suggests 
that the LPO system is bactericidal against C. jejuni if applied on food processing surfaces.
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Figure (24) Survival of C jejuni 11168 on filter membrane with LP system (A), pasteurized milk (A) and water (■), incubated aerobically 
at 25°C. Each point represent the mean logarithm of counts of the organism performed in duplicate and the arrows indicate samples where 
Campylobacter was not detected.
To confirm the previous observation that the effect of LPO system is pronounced and 
bactericidal against C. jejuni on filter membranes, survival of the organism was assessed 
using a more complicated surface, chicken skin (Figure 25). Twenty four portions of 
chicken skin were cut to a diameter of 10 cm per piece. Each piece was inoculated with 1 
ml of known numbers of C. jejuni (10^). Exposure of C. jejuni to the LPO system and 
pasteurized milk did not influence survival in this case and the survival of the organism 
remained constant without any change in viable count up to 24 h of incubation at 25°C in 
the presence or absence of the LPO system. This result suggests that there is not a simple 
application for pasteurized milk as a natural antimicrobial agent to eliminate the presence 
of Campylobacter on the surface of chicken skin
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Figure (25) Survival of C. jejuni on chicken skin with water (■), pasteurized milk (A)  and LPS (A), incubated aerobically at 25X . Each 
point represents the mean logarithm of counts of the organism performed in duplicate.
3.9 Helicobacter pylori behave differently to C. jejuni in UHT skimmed 
milk in the presence of LPO system.
Helicobacters possess properties similar to Campylobacters, and both genera occupy the 
epsilon subgroup of the Proteobacteria, and are related (Todar, 2008). They are gram 
negative, flagellate, spiral bacteria (Penn, 2001). H. pylori is a very important bacterial 
pathogen of humans and causes chronic gastrointestinal illnesses such as peptic and 
duodenal ulcers (EUROGAST study group, 1993). The similarities in their genotypes 
(Shin, et. al, 2002) suggested that H. pylori, a major human pathogen might also be 
susceptible to the antimicrobial LPO system. However, when the sensitivity of this 
bacterium was assessed, the result (Figure 26) showed that H. pylori did not exhibit any 
sensitivity when exposed to the complete LPO system reconstituted in UHT. The viable 
count reduced steadily by < 1 log cycle after 9 h to undetectable level after 24 h. A. similar 
survival profile was observed in the control sample where no LPO system was added, 
suggesting that H. pylori is not sensitive to the LPO system in contrast to the foodborne 
pathogen C. jejuni which showed a significant sensitivity to the same system.
88
Time (h)
Figure (26) Survival of H. pylori control (■), LPO system (□), in UHT skimmed milk incubated aerobically at 25°C. Each point represents 
the mean logarithm of counts of the organism performed in duplicate and the arrows indicate samples where Helicobacter was not 
detected
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CHAPTER 4 
DISCUSSION
4.1. Cow’s Milk
In reviewing the literature, very little data was found on the association between the 
lactoperoxidase enzyme in pasteurized cow’s milk and the survival of Campylobacter in 
this type of milk at 25°C under aerobic conditions. Therefore, this study was initiated with 
the aim of assessing the importance of LPO system on the survival of Campylobacter m 
milk.
In this study the recovery of C. jejuni using three media was investigated to determine the 
most suitable medium for the isolation of C. jejuni from milk. mCCDA and SKM are 
selective media whereas MHA is a general medium without any selective supplements. 
mCCDA and SKM were found to be the most effective recovery media whilst MHA 
generally gave lower recovery and this finding maybe related to the absence of oxygen 
scavenging agents (blood and charcoal). These findings agreed with a previous study 
conducted by Bolton, et. al. (1984), which reported that CCD agar, gave a better recovery 
rate of Campylobacter strains from human samples than Preston agar when cultures were 
examined at 24 h. However when the plates were examined at 42 h a similar rate of 
isolation was recorded for both media. Others have also found that the isolation and 
recovery of C. jejuni using CCD A, SKM and charcoal based medium (CSM) was very 
high from faecal samples in comparison to other media such as semisolid motility agar 
(SSM) and CampyBAP. (Endtz, et. al., 1991). In a study that directly compared mCCDA 
and SKM, the former was noticeably more selective and recovered significantly more C. 
jejuni and C. coli after 48 h of incubation period than SKM. In the same study the authors 
also showed that using a longer incubation time of 5 to 6 days, about 7% of C. jejuni and 
C. coli were recovered with mCCDA from human clinical specimens compared to 4% with 
SKM (Engberg, et. al., 2000). All previous studies showed that the best recovery of 
Campylobacter from clinical specimens happened on mCCD agar. The findings here 
confirm that mCCDA agar gave rise to better recovery of the organism, and therefore it can 
be recommended to be used to recover Campylobacters from food samples such as milk. 
Consequently, it was decided to use mCCDA medium to examine the recovery of 
Campylobacter from food samples.
Although in the present study MHA gave lower recovery than the other two media, the 
overall recovery rate of C. jejuni cells was high. Similar results were obtained in a study by 
Ng, et. al. (1985) which showed that MHA gives high recovery rates of C. jejuni and C.
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coli when pure cultures are plated on this medium. Consequently, MHA may be a suitable 
recovery media especially if pure cultures of C. jejuni and Cxoli or samples with a low 
concentration of competing microflora such as milk are used.
Pasteurized skimmed milk is heated at 72°C for 15 seconds and this process eliminates 
most vegetative bacteria particularly vegetative pathogens and does not, as the results 
present here show, eliminate all endogenous enzyme activity. UHT skimmed milk however 
is sterilized by heating at 135°C for at least one second and this destroys any harmful 
bacteria, including many spore formers, and also antimicrobial enzymes in milk (Adams & 
Moss, 2008). Because of this difference C. jejuni showed differential survival in 
pasteurized and UHT skimmed milk.
C. jejuni viable counts rapidly decreased when the bacterium was inoculated into 
pasteurized skimmed milk. The present study determined that a large part of this 
antibacterial action could be attributed to the natural antimicrobial enzyme LP that exists in 
raw milk, pasteurized milk but not in UHT milk.
Temperature was found to be an important factor affecting the survival of C. jejuni in milk, 
with death occurring more rapidly at 25°C than at 4°C., Similar observations have been 
reported previously by Blaser, et. al. (1980) who found that in autoclaved sterile milk 
initially containing >10^ cfu/ml, C. jejuni could survive for up to 22 days at 4°C but did not 
survive more than 3 days at 25°C. Christopher, et. al. (1982) also reported that a 4-log 
decline in cell count occurred in sterile skimmed milk after 14 days when incubated at 1°C 
and that a 5 to 6-log decrease happened after 2.5 days at 20°C. In addition, Svedhem, et. al. 
(1981), studied the survival of C. jejuni in different food matrices and found that C. jejuni 
when incubated at 4°C remained at a count of approximately 5-log for at least 7 days, 
whilst during storage at 20°C the count decreased rapidly by 3-logs and the organism could 
not be isolated after 3 days. Furthermore study by Barrell, revealed that four out of seven 
strains of C. jejuni were recovered after 48 h when stored at refrigeration temperature and 
one strain was detected after 5 days, whereas only two strains were recoverable after 48 h 
at 2I°C (Barrell, 1981). The effect of temperature on the survival of Campylobacters also 
extends to water as the survival of C. jejuni in surface water and water microcosms was 
limited to a few days in a temperature of 20°C, whilst the survival was markedly improved 
for up to several weeks by storing the samples at 4°C (Buswell, et. al., 1998; Terzieva & 
McFeters, 1991). Finally, a study by Rollins and Colwell (1986) showed that the storage of
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c. jejuni at 4°C could prolong the survival of the organism and that it could remain in 
viable but non-culturable phase for approximately 4 months. Combined with the fact that 
milk is an excellent buffer of gastric acidity (Blaser, et. al, 1979; Robinson, et. al, 1979); 
even samples containing just a few organisms will be sufficient to initiate human infection 
(Blaser, et. a l  1980). This highlights the importance of milk as a Campylobacter vector. 
This current study found that C. jejuni can most likely survive in milk for several weeks 
when ineubated at low temperatures aerobically.
When the survival of C. jejuni was compared in pasteurized and UHT milk, it was found 
that the viable count of C. jejuni declined sharply in pasteurized skimmed milk incubated 
aerobically but that survival was higher in UHT milk. Filtration of pasteurized milk to 
remove the residual natural flora to determine whether this had any impact on survival 
showed that the death rate was the same and that the effect was not due to inhibition by the 
normal micro-flora. In a study which assessed the survival of C. jejuni in raw, pasteurized 
and UHT goat’s milk by Simms & Mac Rae, the survival of C. jejuni in pasteurized goat’s 
milk was shown to be better than in raw milk at 5°C and IO°C than at 15°C and 20°C, 
suggesting, as with the current study that the presence of the antimicrobial activity of LPO 
system was involved and was much stronger in raw milk than in pasteurized milk. The 
study also showed that the competition from the very high initial aerobic mesophilic 
population in the pasteurized goat’s milk did not appear to affect the survival of C. jejuni 
(Simms & Mac Rae, 1989). The result of this eurrent study indicates that LP could play a 
major role in killing Campylobacter and that the competitive micro-flora has no effect on 
its survival when the cow’s milk is kept at 25°C in aerobic conditions.
In a previous study by Beumer, the authors suggested that in bovine raw milk the reduction 
in the eount of C. jejuni was due to the antibacterial activity of the lactoperoxidase system 
but he did not investigate further to eonfirm his observation (Beumer, et. al., 1985). 
Consequently this current study set out to determine whether LP was responsible for the 
killing of C. jejuni in pasteurized milk.
Sodium meta-bisulphite has been widely used as a specific inhibitor of the lactoperoxidase 
enzyme (Borch, et. al, 1989). In our study the survival of C. jejuni with natural LPO 
system in pasteurized skimmed milk containing meta-bisulphite was strongly enhanced 
compared to the control samples. This result is consistent with the results reported by 
Borch, who confirmed that addition of I mM of filter sterilized sodium-pyrosulfite
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completely inhibited the bactericidal effect of the laboratory prepared and added 
lactoperoxidase enzyme to UHT milk against strains of C. jejuni and C. coli (Borch, et. al, 
1989) Beumer et. al. (1985) also demonstrated that in high temperature pasteurized (10s at 
85°C) or sterilized milk (20 min at 110°C), C. jejuni survived very well in comparison to 
milk which had been pasteurized at lower temperatures (15s at 72°C or 30 min at 63°C). 
These findings suggest that in milk treated at high temperature the endogenous LP enzyme 
is destroyed while in milk heat treated to a lesser extent, the enzyme still remains in an 
active form at least to some extent.
Further investigation by Borch showed that using a purified LPO system was bactericidal 
against two strains of C  jejuni and two strains of C. coli isolated from poultry and that 
activity was dependent on the pH and temperature. The bactericidal effect of the LPO 
system was higher at 37°C than 20°C, and the effect was decreased with decreasing pH. At 
pH 6.6 the bactericidal effect was high in comparison with pH 6.0 and pH 5.5. (Borch, et. 
al., 1989). In this current study it was shown that the effect of the naturally existing LP 
enzyme in pasteurized milk had a bactericidal effect on strains of C. jejuni and C. coli 
especially when incubated aerobically at 25°C.
Catalase, an enzyme that catalyzes the breakdown of H2 O2  to oxygen and water, is 
produced by almost all aerobic organisms, including bacteria, human and many 
microaerophilic and aerotolerant species. This wide distribution reflects the toxic nature of 
hydrogen peroxide that can induce single- and double-stranded breaks in DNA and oxidize 
biological membranes and proteins (Storz, et. al. 1990). As catalase removes H2 O2  one of 
the main substrates for LPO system, it ean be used to inhibit the activity of LP (Steele and 
Morrison, 1969), To further confirm that LP activity was responsible for the killing of 
Campylobacters in pasteurized but not UHT milk, the effect of catalase on the survival of 
C. jejuni in pasteurized skimmed milk was examined by adding various concentrations of 
catalase enzyme (100, 500 & 1000) units/ml. Interestingly, at higher concentrations (1000 
units), catalase dramatically improved survival of C. jejuni in pasteurized milk, presumably 
through its indirect inhibition of the LPO system by removing H2 O2 .
All the above experiments investigated the effect of LP activity existing naturally in 
pasteurized milk. For further confirmation that the LPO system was killing Campylobacter 
in pasteurized milk, the system was reconstituted in UHT milk. The addition of 
lactoperoxidase, SON' or H2 O2  individually had no effect on the survival rate, whereas, the
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addition of LP and H2 O2  together produced a noticeable bactericidal effect on C. jejuni and 
addition of the complete LPO system showed a complete bactericidal effect on the 
organism. This showed the critical importance of the presence of the enzyme and hydrogen 
peroxide. Jacob, et. ah, (2000) also showed that the addition of LP alone from goat milk 
had no effect on the survival of Citrobacter Jreundi and Pseudomonas aeruginosa yet 
when the entire LP-H202-thiocyanate system was used, cells were sensitive. This finding 
suggests that LPO system requires the presence of all three eomponents for maximum 
effect. Adamson and Carlsson, et. ah (1982) showed that the survival of E. coli was 
reduced when 1 mM hydrogen peroxide was added to a lactoperoxidase system and that LP 
activity was not influenced by the absence or presence of additional thiocyanate. Other, 
researchers found that the addition of hydrogen peroxide to an LPO system increased its 
antibacterial activity against strains of oral streptococci (Thomas, et. al, 1994).
Naidu (2000) showed that the LPO system inhibited the growth of many bacterial species 
in cow’s milk. Since the composition of milk is different among different species, the LP 
enzyme possesses various activities (Sarkar and Misra, 1994). For example, Zapico, et. ah,
(1991) reported significant differences in LP activity and SON' concentration in the milk of 
Verata and Murciano-Granadina goats. This observation agreed with our finding where the 
measurement of LP and SCN‘ varied greatly in different types of milk. In pasteurized milk 
the level of LP was more than in UHT milk due to the high temperature which destroyed 
the presence of LP in UHT milk. Similarly the concentration of SCN' was found to be 
higher in all types of pasteurized milk than in types of UHT milk (Table 3) in (section 3.2).
In this current study most work was conducted with C. jejuni NCTC1I168. A panel of 
Campylobacter strains were assessed to determine whether the effect of pasteurized milk 
and LP activity was strain specific or a general phenomenon. In general, all strains (10 of 
C. jejuni and 9 of C. coli) survived less well in pasteurized milk compared to UHT milk 
suggesting that all tested strains showed sensitivity to the residual LP aetivity in 
pasteurised milk. There were, however some strain showed specific differences in survival. 
For example, C. coli NCTC 11350, survived the longest; up to 47 h. Strain variation, in 
terms of differential resistance and sensitivity, is a eommon phenomenon when 
Campylobacters are assessed for tolerance to environmental conditions. For example, 
Doyle and Roman demonstrated that in milk held at 4°C, bovine isolates exhibited less 
than 2- log reduction in viable count after 14 days, whilst the viability of strains of human
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origin fell more than 6-logs and declined to undetectable levels in same condition (Doyle 
and Roman, 1982).
C. jejuni was found to be very sensitive to the lactoperoxidase enzyme in pasteurized 
skimmed milk when compared with other food-home pathogens such as S. Enteritidis, E. 
coli 0157:H7and L. monocytogenes. When tested, no significant activity was detected 
against these organisms which grew readily in pasteurized milk after a short lag phase. A 
similar observation was reported by Garcia-Graells, et. al. (2003) who showed that the 
addition of lactoperoxidase system did not affect the survival of Salmonella Typhimurium 
when incubated at 20°C for 24 h in skim milk samples. In eontrast. Touch et. al, (2004) 
showed that the LPO system inhibited the growth of Salmonella Enteritidis in UHT whole 
milk and skimmed milk for about 4 hrs, after which no inhibitory effects were observed. 
Some studies have shown that the LPO system is active against E. coli with the bacteria 
being killed by exposure to hypothiocyanate, the end product of the LPO system (Marshall 
& Reiter, 1980). Another study demonstrating that survival of E. coli 0157:H7 was 
reduced by 2 logs when LPO system was activated in UHT milk (Bleumink, et. al., 1997). 
Furthermore, Farrag, et. al. (1992) found an inhibitory effect of LPO system on E. coli 
0157:H7, with the organism was fully suppressed at low baeterial loads (10"^  efu/ml), 
whereas, the growth was inhibited with the higher loads (10^ cfu/ml). The same author also 
reported that the activity of LPO system was more at 30°C than 4°C and the effect of 
killing was increased by decreasing the pH. In contrast Garcia-Graells, et. al. (2000) made 
similar conclusions to this current study when they tested four strains of E. coli in UHT 
skimmed milk with an added active LPO system and found no effect on growth in the first 
6 h and no bactericidal activity. It seems then that for E. coli at least, that the LPO system 
alone eannot be used to improve the safety of the milk. It may however be more effeetive 
when used in combination with other antimicrobial treatments as demonstrated by McLay, 
et. al. (2002) who found that a combination of the LPO system and monolaurin (ML) 
prevented the growth o f E. coli 0157:H7 in milk whereas when the individual agents had 
no effeet. The most interesting finding of this eurrent study was the unique sensitivity of 
Campylobacters to the LP system, and to the residual activity that is naturally present in 
pasteurized milk.
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For the Gram positive pathogen, L. monocytogenes, the residual LPO system in pasteurized 
milk had little antibacterial activity and the organism was able to grow. Similar 
observations have been reported by Gareia-Graells, et. al. (2000), when different strains of 
Listeria innocua were used as a surrogate for L. monocytogenes. In contrast, Siragusa and 
Johnson (1989) revealed that an activated LPO system inhibited the growth of L. 
monocytogenes Scott A cells in milk in the form of a longer lag period. These conflicting 
results could be due to the different types of strains used in various studies or different 
concentration of LPO system used. But it is elear that the LPO system has a bacteriostatic 
rather than bactericidal effect on gram positive bacteria.
Other bacteria also display sensitivity to the LPO system. Bjorck, et. al, (1975) showed 
that in raw milk containing 0.17 mM of SCN", the viable count of Pseudomonas 
fluorescens decreased rapidly in the first 4 h of incubation, remained almost static in the 
next 6 h, then increased at approximately the same rate as the control. In another study the 
LPO system was shown to exert an inhibitory effect on Pseudomonas aeruginosa over a 10 
h incubation period, after which the organism re-grew and gained viability 5 h later (Fweja, 
et. al, 2008). Santos, et. al., (1994) showed that skimmed and ewe’s milk activated with the 
LPO system was bactericidal against Aeromonas hydrophila Here, the tested organism was 
completely inactivated after 24 h and 2 h respectively, and then remained undetectable 
during storage for up to 25 days. Gurtler & Beuchat (2007) reported that growth of 
Enter oh acter sakazakii was signifieantly inhibited for up to 12 h in reconstituted powdered 
infant formula eontaining 10 pg/ml of LPO system with no notable growth occurring up to 
24 h. In recent studies it was found that lactoperoxidase purified from eows had strong 
antibacterial activity against Brevihacillus centrosaurus, B. choshinensis, B. lyticum, 
Cedecea davisae, Chryseohacterium indoltheticum, Clavibacter michiganensepv. 
insidiosum, Kocuria erythromyxa, K. kristinae, K. rosea, K. varions, Paenibacillus validus. 
Pseudomonas syringae pv. populans, Ralstonia pickettii, Rhodococcus wratislaviensis, 
Serratia fonticola, Streptomyces viola ceusniger. Vibrio cholerae-non Ol, and 
concentration of the three components are very important sueh as LPO-100 mM 
thiocyanate-100 mM hydrogen peroxide system was recommended to be added to the 
medium for effective results (Cankaya, et. al., 2010).
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Xanthine oxidoreductase (XOR) catalyses the anaerobic reduction of inorganic nitrite to 
nitric oxide (NO) (Godber, et. al., 2000a). In the presence of oxygen, the later is reduced to 
superoxide by XOR and this rapidly with NO to form peroxynitrite (Godber, et. al., 
2000b). The peroxynitrite and NO generated by XOR have been found to have strong 
antibacterial properties in milk (Brunelli, et. ah, 1995). When XOR is specifically 
activated by the provision of nitrite, it can reduce the survival of pathogens like E. coli in 
milk (Stevens, et. ah, 2000; Hancock, et. ah, 2002). In this study XOR activity was not 
found to be responsible for the anti-Campylobacter aetivity seen in pasteurized milk. The 
XOR inhibitor oxypurinol (Arai, et. ah, 1998) was found to increase the survival of C. 
jejuni slightly in eomparison to the control milk sample. Surprisingly, the addition of XOR 
enzyme to UHT skimmed milk did not give rise to any antimicrobial effect against C. 
jejuni, confirming that the death of Campylobacter in pasteurized milk was due to the 
presence of LP activity rather than XOR activity.
The LPO system brings about the killing of bacteria via short lived oxidized intermediates, 
and requires hydrogen peroxide for activity (Aune and Thomas, 1977). XOR is bactericidal 
through its ability to generate NO, superoxide and peroxynitrite (Godber, et. ah, 2000a). 
As a consequence of this, it was decided to determine whether mutants of C. jejuni 
deficient in various aspects of the oxidative and nitrosative stress showed altered survival 
in pasteurized milk. The key aspects of the defence against oxidative stress in 
eampylobacter are superoxide dismutase (Pesci, et. ah, 1994) and catalase (Grant and Park, 
1995), and it was decided to assess mutants deficient in these enzymes in comparison with 
the parental strain. A sodB mutant deficient in superoxide dismutase is already available 
(Purdy and Park, 1994; Elvers, K. 2004 (unpublished data), but whilst a katA mutant has 
been made in C. coli (Grant and Park 1995), none is available in strain NCTC 11168, and it 
was thus necessary to eonstruct a mutation in this strain. Finally, the survival of a mutant 
deficient in Cgb, the major component of the nitrosative stress defence of C. jejuni (Elvers 
et. ah, 2004) was characterized to determine whether the production of nitrosative stress 
via XOR (Ungvari, et. ah, 2005) had any influence on the survival of Campylobacters in 
pasteurized milk. The absence of the key enzymes in the mutants cgb, sodB and katA did 
not reduce the ability of C. jejuni to survive in pasteurized milk, suggesting that oxidative 
and nitrosative stress do not contribute to the killing of Campylobacter in pasteurized milk.
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Contamination with Campylobacter through catering surfaces in contact with raw poultry 
has been reported previously (Dawkins, et. al., 1984) and it is thought that the high 
moisture content of certain catering environments eould help the organism survive longer 
on surfaces (Coates, et. al., 1987). The potential practieal application, of the antibaeterial 
activity of the lactoperoxidase system (LPO) against Campylobacter established in this 
current study, was also assessed. The LPO system was reconstituted on a variety of 
artificially contaminated surfaces. When C. jejuni was present on a filter membrane, it was 
very sensitive to the LPO system and the antimicrobial effect was similar to that seen in 
pasteurized milk. This observation suggests that the antimicrobial activity of LPO system 
is retained when applied on surfaces contaminated with C. jejuni, and thus, the system may 
be applied to various aspects of food processing to eradicate the organism. It is worth 
noting, that the system is natural and this may help with consumer acceptance.
In contrast, when the activity of the LPO system in pasteurized milk was assessed on a 
chicken skin surface, the organisms exhibited prolonged survival up to 24 h even when 
exposed to LPO system irrespective of whether it was naturally present in pasteurized milk 
or reconstituted fi-om it individual components. A study by Davis and Conner (2007) 
showed that the survival of Campylobacter on chieken skin at 25°C was enhanced when 
compared to the survival on the meat. Populations of Campylobacter were highest on day 
one and generally decreased until day seven. C. jejuni has been reported to have an affinity 
for the skin and this organ may provide niche protective environments like skin crevices 
and feather follicles (Chantarapanont, et. al. 2003). As a consequence of this, the complex, 
irregular character of chicken skin, and its rough and greasy surface, probably prevented 
the LPO solution gaining access to the eampylobacters.
The effect of LPO system was extended to include H. pylori which is considered to be 
related to eampylobacters. H.pylori is known as the major cause of human gastritis and 
stomach ulcers. These bacteria are similar to Campylobacter in being gram-negative with 
eurved or spiral shaped and they are also genetically related (Shin, et. al, 2002). It is 
believed by some authors that the transmission of H. pylori via eontaminated food can 
occur and milk may act as vehicle of infeetion (Quaglia, et. al, 2007). Because of these 
similarities between Helicobacter and Campylobacer, in the present work, the effect of the 
LPO system on the survival of H. pylori in UHT skimmed milk was investigated. The 
results showed that the LPO system had no significant effect on the survival of H. pylori in
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UHT milk when a concentration of 30mg/L, 14mg/L and 30 mg/L of lactoperoxidase 
enzyme, thiocyanate ion and hydrogen peroxide were used, respectively. This result 
disagrees with the study eonducted by Shin and coworkers (2002) who showed that the 
system composed of peroxidase, H2 O2  and SCN’, exerts antimicrobial effects against H. 
pylori. In his study, the 12 strains tested were all inhibited by the above system in BHI 
broth containing fetal calf serum. However, clinical isolate were most susceptible to the 
LPO system. The difference in results could be due to the type of matrix used, strains and 
temperature. Moreover the concentration of the peroxidase system eould also play role in 
the antimicrobial effectiveness against H. pylori. It is worth mentioning that a study by 
Quaglia, (2007) demonstrated that H. pylori survived in artificially contaminated 
pasteurized and UHT milk for 9 days and 12 days, respectively when ineubated at 4°C. In 
our current study C. jejuni survived for no more than 5 days in pasteurized milk incubated 
under the same conditions suggesting that H. pylori is less sensitive to the lactoperoxidase 
system in comparison to C. jejuni.
4.2 Camel’s milk
Camel’s milk is considered to be one of the most important and valuable food resources for 
pastoral people in arid and semi-arid areas. The consumption of camel milk amongst urban 
people has been increasing in recent times (Chaibou, 2005; Farah, 2004). As this project 
has investigated the effect of LPO system in bovine milk against C. jejuni, a comparison 
study was done using camel’s milk C. jejuni survived with no loss in viability upto 47 h 
when incubated at 4°C and 25°C, irrespective of whether the milk had been boiled to 
remove naturally existing LP suggesting the camel’s milk LPO has little antimicrobial 
activity towards Campylobacter at least. In this respect, lysozyme has been suggested to be 
the main component responsible for the inhibitory activity (Barbour, et. a/., 1984) in 
camel’s milk. Some researchers, however have found that eamel’s milk LP showed a 
similar activity pattern as seen for cow’s LP and the antimicrobial mechanisms of the 
system also as being the same and bacteriostatic against gram positive bacteria and 
bactericidal against gram negative bacteria (El Agami, et. al., 1992). The findings of 
Benkerroum, (2004), are in agreement with our observation but on different organism, he 
reported that L. monocytogenes exhibited a constant survival rate in the first 8 h of 
incubation, however, the bacteria started to grow afterwards (Benkerroum, et. a/.,2004).
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4.2.1. APC
The overall low microbial contamination of raw milk is consistent with the European 
Union standards for raw cow’ milk. It is not specified in these standards, if the camel’s 
milk must meet same criteria previously established for milk fi-om other animals including 
cows. For example, in Franee, the farmers were forced to have the quality of milk for sale 
to be less than 5 x lO"^  cfu/ml (Magras and Tartrou, 2007). At present there are no 
microbiological standards for camel’s milk and its products so the microbiological limits 
for cow’s milk were used to assess the quality of camel milk (El-Ziney and Al-Turki, 
2007). All the sample of camel milk collected during our study showed bacterial count that 
met this criterion. Our results are in agreement with those reported for Saudi (5.4 log 
cfu/ml in average) and Ethiopian (5.6 log cfu/ml in average) camel’s milk (A1 Mohizea 
1994; Semereab and Molla 2001. The low counts in our samples indicates the high quality 
hygiene procedures used in the Emirates Industries for milking eamels.
4.2.2. Conforms
In the present study all 66 samples of raw camel milk were negative for coliforms. 
However, some authors reported the presence of coliforms in healthy camel’s milk with 
values between 1.4% (Wemery, et. a/.,2002) and 29.4% (Saad and Thabet, 1993). As 
coliforms can be a sign of improper hygienic conditions and to a minor degree of faecal 
contamination (Bulte, 2004) the prevalence may vary eonsiderably aceording to hygiene 
conditions.
4.2.3. Escherichia coli
No E. coli was isolated from raw camel milk samples of healthy camels collected for this 
study. Many other authors reported the prevalence of E. coli between 1.0 and 17.3 % in 
samples taken from healthy camels (El Jakee, 1998; Abdel Gadir, et. «7,2005). Since E. 
coli lives normally in intestinal (Bulte, 2004), the presenee of this bacterium in milk cannot 
be fully avoided, however, it can be minimised using a good hygiene practice. As eamel 
faeces are dry and normally do not contaminate the udder skin, this factor can be largely 
excluded in comparison to cows.
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4.2.4. Salmonella
All 66 samples of raw eamel milk were negative for the presence of Salmonella spp. in 25 
ml. However, salmonella infeetion were found to be occurring in neighbouring countries of 
the UAE (OIE, 2004) and the findings of El-Ziney and Al-Turki (2006) who isolated 
Salmonella in 24% of the tested camel milk samples in Egypt, the examination for 
Salmonella should be integrated in the examination scheme if camel milk is produced in a 
large scale dairy farm.
4.2.5. Campylobacter
All 171 samples of camel raw milk were negative for eampylobacters. This result is in 
agreement with the study condueted by Wemary (2002), when he examined 1313 samples 
of raw camel milk and found all of them were negative for the presenee of Campylobacter 
spp (Wernary, et. «7,2002).
These negative results against the occurrence of most pathogenic bacteria might be due to 
the activity of protective proteins (Lysozyme, lactoferrin and lactoperoxidase) of camel’s 
milk, as reported by Barbour, et. «7,(1984). While, El-Agamy (1992) has found that eamel 
milk lysozyme (LZ) was effective against Salmonella, and that camel milk 
Lactoperoxidase was bacteriostatic against the gram positive bacteria and was baetericidal 
against gram negative strains.
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CONCLUSION
The LPO system is an effective and natural antimicrobial system without undesirable 
side effects. The effect of this enzyme system was high in pasteurized milk eompared 
to UHT milk due to the difference in the levels of heat treatment. The findings here 
show that there is clear difference in the activity of LPO system in cow’s milk 
compared with that from camel’s milk, with the latter having very little impact on 
Campylobacter survival. Amongst the organisms tested {S. Enteritidis, L. 
monocytogenes and E. coli 0157:H7) eampylobacters showed a unique sensitivty to 
the LP system and this study also showed that the LPO system present in pasteurized 
milk eould be used to eliminate Campylobacter on artificial surfaces. The system was 
ineffective on more complex surfaces such as chicken skin but might prove effeetive 
if used with other agents, such as mild detergents, as these would allow better 
dispersal.
This projeet offers many avenues for fiirther research. These are listed below:
• The LP system eould be eombined with other treatments, such as mild detergents to 
improve its effectiveness on raw meat surfaces. It might be possible to optimise the 
formulation to ensure wetting of the surfaces and access to the bacteria.
• What is responsible for the hypersensitivity of eampylobacters to the LP system 
compared to other and related bacteria. This might be elucidated by a study a 
mutants of other bacteria that have beeome sensitive to the system.
• The effect of LPO system present naturally in pasteurized milk or prepared in the 
laboratory needs to be further tested on H.pylori to reconeile the differences 
between what has been observed here and by others. More strains should be 
examined to determine whether strain differences are present.
• Further field studies are required into the incidence of Campylobacter in camel’s 
milk and the potential role of LPO system may play in its control.
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6. APPENDICES
All reagents and chemicals used were obtained from Sigma Aldrich (Poole, Dorset) unless 
otherwise stated.
A- Culture Media
All culture media were obtained from Oxiod (Basinstoke) and prepared using distilled 
water. Sterilization was carried out by autocjaving at 12 TC for 15 min at 15 pounds per 
square inch (p.s.i.) unless stated. Blood and antibiotics were added to warm (50°C) media. 
The media plates were stored at 4°C.
Levine's EMB Agar
lO.Og
Peptone
Lactose lO.Og
Di-Potassium Monohydrogen Phosphate 2.0g 
Eosin Y 0.4g
(Methylene Blue) 0.06g
Agar 15.0g
Distilled Water 1 L
Hektoen Enteric Agar
Proteose Peptone 12.0g
Yeast Extract Powder 3.0g
Lactose 12.0g
Sucrose 12.0g
Salicin 2.0g
Bile Salts No.3 9.0g
Sodium Chloride 5.0g
Sodium Thiosulfate 5.0g
Ammonium Ferric Citrate 1.5g
Acid Fuchsin O.lg
Bromthymol Blue 0.065g
Agar 14.0g
Distilled Water 1 L
Suspend ingredients or the prescribed amount of the complete dehydrated medium in 
distilled water and soak for 1 0  minutes, then heat gently and allow boiling for a few 
seconds to dissolve the agar. DO NOT OVERHEAT -final pH 7.5 + 0.2 Cool to 50+ 1 °C 
and pour approximate 20ml into sterile plates. Plates may be refrigerated for future use
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Luria-Bertani (LB) Agar
Tiyptone 2 g
Yeast Extract Ig
Sodium Chloride 2 g
Agar 3g
Distilled Water 2 0 0 ml
Lysine Iron Agar (LIA)
Bacteriological Peptone 54g
Yeast Extract l a g
Dextrose l.Og
L-Lysine lO.Og
Ferric Ammonium Citrate OJg
Sodium Thiosulfate 0.04g
Bromeresol Purple 0 .0 2 g
Agar 14.5g
Distilled Water 1 .L
Suspend ingredients or the prescribed amount of the complete dehydrated medium in 
distilled water. Bring to the boil to dissolve completely. Dispense in 6 -ml portions into
tubes and sterilize by autoclaving at 121+ 1°C for 15 minutes. Allow the medium to set in
slope form with a butt of about 1 inch.
Mueller-Hinton Agar
Mueller Hintor Agar 3 8 g
Distilled Water 1 L
Modified Semisolid, Rappaport Vassilidis (MSRV) Medium Base
Tryptose 4.59g
Casein Hydrolysate 4.59g
Sodium Chloride 7.34g
Potassium Dihydrogen Phosphate 1.47g
Magnesium Chloride Anhydrous 10.93g
Malachite Green Oxalate 0.037g
Agar 2.7g
Suspend 15.8g in 500ml of distilled or deionized water and bring to the boil with frequent 
agitation. DO NOT AUTOCLAVE. Cool to 50+ 1°C and aseptically add the contents of 1 
vial of MSRV selective supplement (Novobiocin lOmg vial) reconstituted with 2ml of
sterile distilled water. Mix well and pour into sterile Petri dishes air dry for at least 1 hour.
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Nutrient Agar
Nutrient Agar 28g
Distilled Water IL
Plate Count Agar
5.0g
Tryptone
Yeast Extract 2.5g
Glucose l.Og
Agar 15.0g
Distilled Water IL
Simmons Citrate Agar
0 2 g
Magnesium sulfate Heptahydrate
Ammonium Dihydrogen Pphosphate l.Og
di-Potassium Hydrogen Phosphate l.Og
Sodium Citrate Dihydrate ZOg
Sodium Chloride 5.0g
Bromthymol Blue 0.08g
Agar 15.0g
Distilled Water IL
Tryptone Bile X-Glucoronoide Medium (TBX)
Tryptone 2 0 .0 g
Bile Salts No. 3 1.5g
Agar 15.0g
X-glucorunide 0.075g
Distilled water IL
Triple Sugar Iron (TSI) Agar
lO g
"Lab-Lemeo" Powder
Yeast Extract lO g
Peptone 2 0 .0 g
Sodium Chloride lOg
Lactose lO.Og
Sucrose lO.Og
Dextrose l.Og
Ferric Citrate OJg
Sodium Thiosulfate OJg
Phenol 0.025g
Agar 1 2 .0 g
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Distilled Water l.L
Suspend ingredients or the prescribed amount of the complete dehydrated medium in 
distilled water. Bring to the boil to dissolve completely. Mix well and distribute in 6 -ml 
portions into 16 xl50mm test tubes-final pH 7.4 ±  0.2, sterilize by autoclaving at 121+ 1°C 
for 15 minutes. Allow the medium to set in slope form with a butt of about 1 inch
Urea Agar
Peptone l.Og
Dextrose ^
Sodium Chloride 5.0g
Disodium Phosphate 1.2g
Potassium Dihydrogen Phosphate 0.8 g
Phenol Red 0.012g
Agar 15.0g
Distilled Water 95.0ml
Suspend basal medium ingredients or the prescribed amount of the complete dehydrated 
basal medium in 95ml distilled water. Bring to the boil to dissolve completely. Sterilize by 
autoclaving at 120°C for 20 minutes. Cool to 50+ 1°C and aseptically introduce 5 ml of 
sterile 40% Urea Solution. Mix well, distribute in 6  ml. amounts into sterile test tubes and 
allow setting in the slope position.
Violet Red Bile Agar (VRBA)
lag
Yeast Extract 
Peptone 7.0g
Sodium Chloride 5.0g
Bile salts or Bile Salts No.3 1.5g
Lactose lO.Og
Neutral red 0.03g
Crystal Violet 0.002g
Agar 15.0g
Distilled Water 1 L
Suspend the ingredients or the prescribed amount of the complete dehydrated medium in 
distilled water and allow standing for a few minutes. Mix thoroughly and adjust to pH 
7.4.+ 0.2 Heat with agitation and boil for 2 minutes or for the minimum time to dissolve 
completely. No further sterilization is required or desirable. Prior to use, cool to 45°C and 
mix well before pouring.
XLD Medium
Yeast Extract 3.0g
L-Lysine HCL 5. Og
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Xylose
Lactose
Sucrose
Sodium Desoxycholate 
Ferric Ammonium Citrate 
Sodium Thiosulfate 
NaCl
Phenol Red 
Agar
Distilled Water
3.75g
7jg
7jg
l.Og
&8 g
6 .8 g
5.0g
0.08g
lZ5g
IL
Dissolve ingredients or the prescribed amount of the complete dehydrated medium in 
distilled water, then heat with frequent agitation just until medium boils. DO NOT 
OVERHEAT - final pH 7.4 + 0.2 Pour approximate 20ml into sterile plates when the 
medium has cooled to 50+ 1°C.
Buffer Peptone W ater
Peptone
NaCl
Disodium Phosphate 
Potassium Dihydrogen Phosphate 
Distilled Water
lOg
Ojg
3.5g
1.5g
IL
Brilliant Green Lactose Bile Broth 2%
Peptone
Lactose
Oxgall
Brilliant Green 
Distilled Water
lO.Og
lO.Og
2 0 .0 g
0.0133g
IL
LB Broth
Tryptone 
Yeast Extract 
Sodium Chloride 
Distilled Water
2 g
Ig
2 g
2 0 0 ml
Mueller-Hinton Broth
Mueller-Hinton Broth 
Distilled Water
2 1 g
IL
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MacConkey Broth
Peptone 
Lactose 
Bile Salts 
Sodium Chloride 
Bromoeresol Purple 
Distilled Water 
MR-VP Broth
Peptone 
Glucose 
K2 HPO4  
Distilled Water
20.0g
lO.Og
5.0g
O.Olg
IL
7.0g
5.0g
IL
Maximum Recovery Diluent (MRD)
Bacteriological Peptone 0.1 g
Natrium Chloride 0.85g
Distilled Water 100ml
Nutrient Broth
Nutrient Broth 
Distilled Water
25g
IL
Tetrathionate Broth
“Lab-Lemeo” Powder 
Peptone 
Yeast Extract 
Sodium Chloride 
Calcium Carbonate 
Sodium Thiosulfate 
Distilled Water
O jg
4.5g
I j g
4.5g
25.0g
40.7g
IL
Suspend ingredients or the prescribed amount of the complete dehydrated medium in 
distilled water, mix well to dissolve soluble materials. Dispense in 10-ml portions into 
sterile test tubes. Heat to boiling, and cool below 45+ 1°C and store at 4+ 1°C. Prior to use, 
add 0.2 ml of the iodine solution to each tube. Agitate gently to mix and re-suspend the 
precipitate.
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Columbia agar Base
19.5 g was suspended in 500 ml of distilled water and brought to boil in order to dissolve 
the medium completely. The medium was sterilized by autoclaving at 121°C for 15 min 
and then was cooled to 50°C. Five percent of sterile laked horse blood and one vial of 
skirrow selective supplement were added to the medium
Listeria Selective Agar Base (Oxford formulation)
22.75 g of this agar was suspended into 500 ml of distilled water and brought to boil to 
dissolve the medium completely. Sterilization took place by autoclaving at 121°C for 15 
min and then was cooled to 50°C. Two ml of distilled water was added in to a vial of dried 
listeria selective supplement (SRI 40) and then was added in the sterilized medium.
Peptone water (Bacteriological peptone)
0.5 g peptone and 4.25 NaCl were added to 500 ml of distilled water. Brought to boil and 
then sterilized by autoclaving at 121°C for 15 min. This medium was prepared as a 0.1% 
solution of Bacto-Peptone and used as the inoculums in all experiments.
B- BUFFERS 
lOX TBE Buffer
To make 1 liter of lOX TBE buffer, 108g Tris Base, 55g Boric Acid, 20ml 0.5M EDTA 
were added with distilled water and volume adjusted to 1 liter.
Tris-EDTA (TE) Buffer
To make 50 ml volum, 0.5 ml Tris-HCL 10 mmol (pH 8 ) and 0.1ml EDTA mmol (pH 8 ) 
was added to 49.4ml distilled water.
C. jejuni Wash Buffer
9g sucrose and 15ml glycerol and distilled water added to make 100ml.
C- Other reagents and Chemicals
Hydrogen peroxide (H202); >30% w/v; FW: 34.01; 0.026M
H2 O2  0.30ml
Distilled Water 99.70ml
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Catalase; 1340 unit/mg
Stock concentration of 50,000 units
Catalase 37.3 mg
PBS 1ml
Ammonium acetate 7.5M
To make 10 ml volume, 5.781 g ammonium acetate was added and made up to 10ml with 
sterile miliQ water and filter sterilised.
GES reagent
To make 100ml volume, 60g guanidium thieyanate was weighed in fume hood and added 
to 20ml EDTA and 20ml sterile distilled water, mixed until dissolved at 65°C. 5ml 10% 
v/v Sarkosyl (N-laurolysarcosine) was added and made up to 100ml with distilled water.
Chloroform and isoamylalcohol 24:1
To make 100ml volume, 96ml chloroform and 4ml isoamylalcohol made up to 100ml with 
distilled water.
1% agarose
To make 200ml volume, Ig agarose was weighed and added with 200ml 0.5X TBE. 
5-bromo-4chloro-3-indolyI-B-D-galactosidase (X-Gal)
1ml of dimethyl formamide was added with 0.04g X-Gal in fume hood.
Iodine Solution
Iodine 6.0g
Postassium Iodide (KI) 5.0g
Distilled Water 20.0ml
Dissolve Potassium iodide in 5 ml sterile distilled water. Add iodine and stir to dissolve. 
Dilute to 20 ml with sterile distilled water and store in the dark.
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Methyl Red Indicator
O.lOg
Methyl Red
Aleohol, 95 % Ethanol 300ml
Distilled Water 200ml
Voges-Proskauer (VP) Test Reagents 
Solution A:
5.0
Alpha-Naphthanol
Absolute Ethanol 100.0
Solution B:
40.0g
Potassium Hydroxide
Distilled Water 100. ml
D. Antibiotics 
Ampicillin
To make 50mg/ml, 0.1 g ampicillin was added to 2ml miliQ water and filter sterilised. 
Kanamycin
To make 50mg/ml, 0.1 g kanamycin was added to 2ml miliQ water and filter sterilised.
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